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Preimplantation genetic diagnosis (PGD) is an alternative reproductive technology 
integrated with in-vitro fertilisation (IVF). It is a well-established technique offering 
reproductive options for families at a high risk of transmitting a genetic disorder, 
allowing them to avoid a termination of pregnancy (TOP). Consanguineous unions are 
common and encouraged in many Arab communities.  This can lead to an increased 
risk of one or more autosomal recessive disorders that may occur within the family. 
Traditional prenatal testing involves testing fetal cells with the option of TOP of an 
affected fetus. In Arab communities where TOP is restricted under Muslim law, such 
testing is not acceptable. For these couples and their family members, PGD is a feasible 
option as the fetus is diagnosed before implantation and allows for only healthy 
embryos to be implanted.  However, undergoing PGD is relatively new in the Arabic 
Muslim countries and Omani patients have only recently had access to the service. 
This study utilised a phenomenological approach to explore the experience of Omani 
families who had selected to undergo PGD as a means of reducing the risk of having 
a child affected with a genetic disorder. Fourteen participants from eight families who 
underwent PGD were interviewed. Data collected were analysed using thematic 
analysis. The research identified five main themes; Desire for a Healthy Child; Anxiety 
“Taraqub”; Unforeseen; Secrecy; Me and My Partner. The PGD experience was 
reported as physically and emotionally distressing. Some participants felt attached to 
their embryos regardless of health status, while the majority did not anticipate the loss 
of intimacy, autonomy and control they experienced, particularly related to the 
insemination process. The social and religious background of participants played a 
significant role in the participant’s perception of PGD, which has both practical and 
psychosocial implications. The findings of the research have provided insight into the 
PGD experiences of Omani families and can be used to improve the services that are 







Acknowledgements   
I would like to personally acknowledge and sincerely thank the following 
individuals, whose contributions have been invaluable and without whom the 
successful completion of this project would not have been made possible: 
 My supervisor, Dr Tina-Marié Wessels, for her valuable guidance, 
continuous support, feedback and recommendations.  
 My co-supervisors and mental mentor, Dr. Zandre Bruwer, for her unlimited 
guidance, support and treasured recommendations. 
 To the families who participated in the research despite their struggles in life; 
whom I learned a lot. To those families and others who could not participate, 
I thank you all for your support and enthusiastic.   
 Prof Jacquie Greenberg, without whom I would not have been given the 
opportunity to be a part of this course and fulfilling my dreams to complete 
my Msc degree in genetic counselling. 
 To my fellow students for their support and to Gill for her invaluable help in 
editing and proof reading.  
 Everyone at the Division of Human Genetics, especially to our clinical team. 
I have learnt so much from you all. 
 Genetic and Developmental Medicine clinical team for their endless support 
and encouragement 
 Dr. Claire Beaudevin, for helping me in qualitative research hiccups. 
 My parents, siblings and other family members who offered unconstrained 
support taking care of my children in my absence.  
 My brothers Ibrahim, Abdulwahab and Mohammed who dedicated their time, 
support and companion crossing the content travelling with me.  
 My children, Husna, Omar and Shurooq, who sacrificed their needs and 
empowered me to continue my study. 
 My husband Ahmed for his unconditional love, support and understanding in 







Declaration ................................................................................................................... 2 
Abstract ....................................................................................................................... 3 
Acknowledgements ..................................................................................................... 4 
Contents ....................................................................................................................... 5 
Appendix A :  Abbreviations ....................................................................................... 8 
Appendix B: list of figures ........................................................................................... 9 
Appendix C: List of tables ........................................................................................... 9 
Chapter 1 .................................................................................................................... 10 
Introduction ............................................................................................................ 10 
Aim of the study ..................................................................................................... 11 
Objectives: .............................................................................................................. 11 
Organisation of the study ....................................................................................... 11 
Chapter 2. Literature review ...................................................................................... 13 
2.1. Introduction ..................................................................................................... 13 
2.2. Literature review ............................................................................................. 13 
2.2.1. Introduction to PGD .................................................................................. 13 
2.2.2. PGD procedure ......................................................................................... 14 
2.2.3. Indications for PGD and technology used ................................................ 17 
2.2.4.   PGD for chromosomal anomalies .............................................................. 18 
2.2.5. PGD for single gene disorders .................................................................. 19 
2.2.6. PGD for mitochondrial disorders ............................................................. 21 
2.2.7. PGD for HLA matching ............................................................................. 21 
2.3. PGD policy and regulations ............................................................................ 22 
2.3.1. PGD Success Rate and Limitations ........................................................... 23 
2.4. Motivations for PGD ....................................................................................... 24 
2.4.1. Avoidance of recurrence risk and TOP ..................................................... 24 
2.4.2. Emotional and psychological experience of PGD ..................................... 26 
2.5. PND and PGD perspectives in Islam .............................................................. 27 
2.6. Health care system in Oman ............................................................................ 29 
2.7. PGD procedure in Oman ................................................................................. 29 
Chapter 3. Methodology............................................................................................. 31 
3.1. Method and Instrumentation ........................................................................... 31 
3.2. Research Design .............................................................................................. 31 
3.3. Population and Sampling Method ................................................................... 32 
3.3.1. Setting ........................................................................................................ 33 
3.3.2. Inclusion criteria ....................................................................................... 34 
6 
 
3.3.3. Exclusion criteria ...................................................................................... 34 
3.4. Measurement Instruments ............................................................................... 34 
3.4.1. Interviews .................................................................................................. 34 
3.4.2. Audio recording ......................................................................................... 35 
3.5. Procedure ......................................................................................................... 35 
3.5.1. Testing interview ....................................................................................... 35 
3.5.2. Recruitment ................................................................................................ 36 
3.5.3. Implementation of interviews .................................................................... 36 
3.6. Data Analysis and Interpretation ..................................................................... 37 
3.7. Trustworthiness and rigour .............................................................................. 39 
3.7.1. Validity ...................................................................................................... 39 
3.7.2. Reflexivity .................................................................................................. 40 
3.8. Ethical Considerations: .................................................................................... 42 
3.9. Risk and benefits to subjects: .......................................................................... 43 
3.10. Strengths and Limitations of the Study ......................................................... 43 
3.10.1.    Limitations ............................................................................................... 43 
3.10.2.   Strengths ................................................................................................... 44 
Chapter 4. Results and discussion .............................................................................. 45 
4.1. Introduction ..................................................................................................... 45 
4.2. Description of participants: ............................................................................. 45 
4.3. Themes identified ................................................................................................ 48 
4.3.1. Theme 1 ........................................................................................................ 49 
4.3.1. Desire for a healthy child ............................................................................. 49 
4.3.1.1.   Longing for a child (window of hope) ..................................................... 49 
4.3.1.2.   Can’t have another affected .................................................................... 53 
4.3.1.3.   Avoidance of TOP.................................................................................... 54 
4.3.2. Theme 2 ........................................................................................................ 56 
4.3.2. Anxiety “Taraqub: Arabic metaphor” .......................................................... 56 
4.3.2.1.   Road to PGD ........................................................................................... 56 
4.3.2.2.   Waiting for exam results .......................................................................... 59 
4.3.2.3.   She was not herself .................................................................................. 62 
4.3.3. Theme 3 ........................................................................................................ 63 
4.3.3. Unforeseen .................................................................................................... 63 
4.3.3.1.   Loss of intimacy and autonomy ............................................................... 63 
4.3.3.2.   A piece of mine ........................................................................................ 65 
4.3.3.3.   Cannot remember a failure rate .............................................................. 68 
4.3.4. Theme 4 ........................................................................................................ 69 
7 
 
4.3.4. Secrecy ......................................................................................................... 69 
4.3.4.1.   PGD child “Haram” (sinful) .................................................................. 69 
4.3.5. Theme 5 ........................................................................................................ 71 
4.3.5. Me and my partner ....................................................................................... 71 
Chapter 5. Conclusion ................................................................................................ 75 
5.1. Introduction ..................................................................................................... 75 
5.2. Conclusion ....................................................................................................... 75 
5.3. Practical implications and recommendations .................................................. 76 
5.4. Recommendations for further study: ............................................................... 78 
References: ................................................................................................................. 80 
Appendix D: ............................................................................................................... 87 
Interview questions in English ................................................................................... 87 
Interview questions in Arabic .................................................................................... 89 
Appendix E: ............................................................................................................... 91 
Invitation for participation in English ........................................................................ 91 
Invitation for participation in Arabic ......................................................................... 92 
Appendix F: ................................................................................................................ 93 
Research Consent Form in English ............................................................................ 93 
Research Consent Form in Arabic ............................................................................. 94 
Appendix G: ............................................................................................................... 95 
UCT ethical approval ................................................................................................. 95 















Appendix A :  Abbreviations 
 
PGD Preimplantation Genetic Diagnosis 
PGS Preimplantation Genetic Screening 
IVF In Vitro Fertilization 
TOP Termination of Pregnancy 
PND Prenatal Diagnosis 
HLA Human Leukocyte Antigen 
aCGH Array comparative Genomic Hybridisation 
SNP Single Nucleotide Polymorphism 
GDM Genetic and Developmental Medicine Clinic 
SQU Sultan Qaboos University 
SQUH Sultan Qaboos University Hospital 
OHSS Ovarian hyper-stimulation syndrome 
GDM Genetic and Developmental Medicine clinic at SQUH 
ESHRE European Society of Human Reproductive and Embryology 
HFEA Human Fertility and Embryology Acta 
US Unites States of America 
UK United Kingdom 
PCR Polymerase Chain Reaction 
FISH Fluorescence in situ hybridisation 
PGDIS PGD International Society 
ICSI Intra cell sperm injection  
ADO Allele drop out 
mtDNA Mitochondrial DNA 
NGS Next generation sequencing 








Appendix B: list of figures 
Fig 1: Timeline for a typical PGD treatment cycle  
Fig 2: Illustrative procedure of PGD 
Fig 3: PGD for common monogenic disorders reported by ESHRE data X 
Appendix C: List of tables 
Table1: Sociodemographic information of participants 
Table 2: Summary of reproductive and PGD family history 





Preimplantation genetic diagnosis (PGD) is a technique combined with In Vitro 
Fertilization (IVF) that has come into existence in the last 20 years (Harper, 2009). 
PGD aims to evaluate a known genetic defect in an embryo (Brezina et al., 2012). It is 
a well-established technology offering a reproductive option for families at a high risk 
of transmitting a genetic disorder enabling them to avoid a termination of pregnancy 
(TOP) (Harper, 2009). 
Consanguineous unions are common and encouraged in many Arab communities, and 
can lead to an increased risk of one or more autosomal recessive disorders that may 
occur within families. The chance of homozygosity in progeny of first double cousins 
is 1/8, first cousins 1/16 and for the second cousins 1/32 (Harper, 2004). For these 
couples and their family members, avoidance of recurrence is particularly important 
(Hamamy, 2012; El-Toukhy, 2014a). Consanguinity is a respected tradition with 
strong social and financial benefits that is practiced among a number of communities 
within North Africa, the Middle East and West Asia (Bittles & Black, 2010; Hamamy, 
2012). In Oman 56% of marriages are consanguineous unions of first or second cousins 
or between relatives within the same tribe (Rajab & El-Hazmi, 2007; Al-Thihli et al., 
2014). A 2008 publication by the Omani Ministry of Health claimed that 39% of 
perinatal deaths were due to malformations and genetic disorders (Rajab, Al Rashdi & 
Al Salmi, 2013). Al-Thihli et al (2014) furthermore reported that 95% of a cohort of 
285 Omani patients with inborn errors of metabolism were identified to be the product 
of consanguineous unions (Al-Thihli et al., 2014). Preventative options such as 
prenatal genetic diagnosis (PND), TOP and PGD can reduce the burden of caring for 
a diseased child or in many instances children with a serious debilitating disorder. In 
contrast to PGD, PND is a method of testing a pregnancy for a genetic disorder and if 
the results indicate an affected fetus the only option for avoidance would be TOP. This 
can cause physical and emotional trauma which may be compounded by grief and guilt 
(Katz et al., 2002). Therefore, PGD is often seen as an alternative to avoid the stress 
of PND and trauma of TOP (El-Toukhy, 2014b). 
In Islam, PGD is allowed when performed by an embryologist who is aware of the 
Islamic regulations in handling human embryos. Individuals in whom the egg and 
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sperm are retrieved must have a recognized Islamic marriage, live together and be alive 
(Atighetchil, 2007; Serour, 2013). 
However, preimplantation genetic diagnosis (PGD) services are not available within 
Oman and families considering PGD have to travel to neighbouring countries to access 
the service. The Genetic and Developmental Medicine Clinic (GDM) at Sultan Qaboos 
University Hospital (SQUH) facilitates the counselling and logistic arrangements for 
families undergoing PGD. On average, the procedure can take as long as 12 to 18 
months before a cycle is started. This has a major psychosocial impact on families 
because of the cultural significance of a large family (El-Hazmi, 2004; Rajab & El-
Hazmi, 2007).  
The demand for the PGD service in Oman has grown exponentially.  During 
2014/2015, the GDM clinic received more than 30 requests, compared to only three in 
2013 (local database). To date, there has been no study on the attitudes and perceptions 
of Omani families towards PGD, and the patients’ needs from the service. This 
situation demands an understanding of the experiences of these families. By gaining 
insight into the impact of the procedure, it is hoped that genetic counselling for future 
families can be improved. Furthermore, knowledge derived from the investigation can 
be extrapolated to developing regulations and guidelines for counselling and 
enrolment of PGD families in Oman.  
Aim of the study 
To explore the experience of Omani families who have selected to undergo PGD as a 
means for reducing the risk of having a child affected with a genetic disorder. 
Objectives: 
 To identify the factors affecting the decision to undergo PGD 
 To explore the couples’ expectations of the PGD procedure 
 To explore the couples’ experience of the PGD enrolment procedure 
 To identify the facilitators and barriers to accessing PGD   
 To determine the recommendations the couples make to improve the service. 
Organisation of the study 
This thesis is organised as follow  
12
 Chapter 2 contains an overview of the current literature on PGD, including
information on the technology, its use and limitations. The author in this
chapter additionally explores published literature concerning the experiences
of families undergoing PGD while at the end of the chapter presents
information on the Islamic perspectives of PND and PGD, and discusses Oman
and the country’s healthcare system.
 In chapter 3, the author explains the research design and methodology used in
the current study. It also describes the participants, the selection criteria,
validity and trustworthiness. The data collection and analysis are described and
the ethical issues involved in the study are considered.
 Chapter 4 contains a discussion of the research study results. The analysis and
discussion are included in the same chapter to prevent unnecessary repetition
of information. It will also integrate comparison with the published literature.
 In chapter 5, the conclusion and summary of the main findings of the study is
presented. At the end recommendations in practice and recommendations for
future research and study is discussed.
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Chapter 2. Literature review 
2.1. Introduction 
This chapter will explore the literature with regards to the historical overview of PGD 
development and utilisation. It will present an overview of the reported motives, 
perspectives and experiences of families who have undertaken PGD. Religious aspects 
regarding PND and PGD will be presented as well in this chapter. This chapter will 
also present the demography of Oman, law, religious and service provided for PGD 
users.   
2.2. Literature review 
The number of studies concerning PGD experience in Islamic and Middle Eastern 
cultures are limited and no literature is available for Omani families. Literature 
searches were conducted using the search terms ‘preimplantation genetic diagnosis’, 
‘PGD’, ‘PGD in Arab countries’, ‘PGD and Muslims’, ‘PGD Oman’, ‘PGD Saudi 
Arabia’, ‘PGD Lebanon’, ‘PGD Qatar’, ‘PGD Bahrain’, ‘PGD Egypt’, ‘PGD Tunis’, 
on EBSCO, ProQuest, Wiley, Pubmed, google search, google scholars, google books, 
Web of Science, ScienceDirect, Scopus, SciVal and Springer.  
2.2.1. Introduction to PGD 
PGD was first successfully performed in a human embryo in 1989 for a sex-linked 
disorder (Handyside et al., 1990). In this first PGD, the pioneering team extracted 
DNA from a biopsy of the cleavage cells for Y- specific DNA amplification 
polymerase chain reaction (PCR) (Flinter & Stewart, 2014; Harper & SenGupta, 
2012). The embryos with absent Y allele were considered female and returned to the 
uterus (Handyside et al., 1990). In 1989 the first unaffected child was born following 
PGD for an X-linked disorder (Harper & SenGupta, 2012). Since then, PGD has been 
used widely for different autosomal recessive and dominant disorders (El-Toukhy, 
2014a). To date, PGD has been implemented for more than 400 disorders - the most 
common include cystic fibrosis, spinal muscular atrophy and hemoglobinopathies 
(Kuliev & Rechitsky, 2015). 
While IVF entails the fertilization of mature oocytes outside the uterus (in a cell culture 
setting) and implanting them back into the uterine cavity (Coughlan, Ledger & Ola, 
2011), PGD aims to evaluate a known genetic defect in an embryo before implantation 
(Brezina et al., 2012). The technology is well-established and offers a reproductive 
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option for families at a high risk of transmitting a genetic disorder which enables them 
to avoid TOP (Harper, 2009). Preimplantation genetic diagnosis is considered an early 
form of PND but without the risk of the procedure-related miscarriage (Ben-Nagi et 
al., 2016; Brezina et al., 2012). 
In addition, there are other benefits such as reduction of parental anxiety as PGD is 
capable of providing a couple with the possibility of starting a pregnancy with the 
knowledge that the fetus is free of the familial genetic disorder (El-Toukhy, 2014a). 
Furthermore, the anxiety related to the decision making process of TOP is removed 
when utilising PGD (Ben-Nagi et al., 2016; Brezina et al., 2012). 
In recent years, different technologies have been developed to provide highly accurate 
methods for genetic testing of the fertilised egg (Brezina et al., 2012; Flinter & Stewart, 
2014; Renwick & Altarescu, 2014). These include fluorescence in situ hybridization 
(FISH) that can be used to target a chromosomal rearrangement; PCR for single gene 
mutations and array CGH for chromosomal aneuploidy (El-Toukhy, 2014a). Each 
procedure is discussed in detail in section 2.2.3. After the introduction of PGD, 
preimplantation genetic screening (PGS) was initiated to exclude chromosomal 
aneuploidies which could reduce the success rate of achieving a healthy pregnancy. 
PGS can be offered to couples with multiple miscarriage or advanced maternal age or 
even together with PGD for couples at risk of transmitting a genetic disease (Ben-Nagi 
et al., 2016; El-Toukhy, 2014a; Harper & SenGupta, 2012; Flinter & Stewart, 2014) 
PGS is provided through FISH or more recently through microarray (Ben-Nagi et al., 
2016; Brezina et al., 2012; El-Toukhy, 2014a). However, PGS technology is very new 
and remains controversial for clinical use (Harton et al., 2011a). 
2.2.2. PGD procedure 
In practice, as recommended by ESHRE and the PGD international society (PGDIS), 
facilitating PGD requires a multidisciplinary team including medical and 
administrative staff (Harton et al., 2011a; Khalaf & Grace, 2014; Lashwood, 2014). 
The couple should be counselled by a qualified geneticist or genetic counsellor and 
provided with psychosocial support. The majority of PGD families have undergone a 
stressful history of disease occurrence or recurrence; loss of affected individuals; 
experience of PND and/ or TOP in addition to being at a high risk of transmitting a 
genetic disease (Harton et al., 2011a; Lashwood, 2014). Genetic counselling is 
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essential to ensure that the couple understands the mode of transmission and recurrence 
risk of the condition affecting their family and to support an informed decision for an 
alternative reproductive option. Limitations of testing and success rate of the procedure 
as well as the potential risk of short or long term effects should be provided prior to 
referral to a PGD centre (Harton et al., 2011a). Preimplantation genetic diagnosis 
(PGD) counselling may occur over several visits as the couple experiences the 
different phases of decision making (Hershberger et al., 2012). Genetic counselling 
should additionally address the potential that no healthy embryos may be available for 
implantation following testing. They should also be informed that the biopsy may 
cause harm to the morphology of the tested embryos rendering them unsuitable for 
implantation.  
Couples interested in PGD usually have no fertility concerns but still require 
assessment and treatment from the infertility/reproductive specialists to ensure that 
they are medically suitable for treatment (Ben-Nagi et al., 2016). However, in a study 
by Horton et al 2011, it was found that 30% of PGD families actually had some 
infertility concerns when the infertility work-up was initiated (Harton et al., 2011a). 
Importantly, the reproductive specialist should provide information regarding the IVF 
treatment, details about IVF/ICSI procedure, risk of medical treatment (ovarian 
hyperstimulation risk) and potential complications during the oocyte retrieval 
procedure (Harton et al., 2011a; Lashwood, 2014). In addition, the chance of potential 
spontaneous pregnancy and need for contraceptives should also be addressed (Harton 
et al., 2011a).   
Following the infertility work-up and investigation, pre-PGD can be initiated. This 
step involves the preparation for PGD testing of the particular genetic mutation and 
can take between six weeks and six months to complete. The actual PGD procedure 
starts after the preparation stage and includes IVF treatment with hormonal induction 
to stimulate oogenesis (Fig1). Counselling should include informing the couple about 
the complications of the treatment and side effects such as the 7.5% risk of ovarian 
torsion, 2.3% risk for ovarian hyper-stimulation syndrome (OHSS); 4.5% risk for early 
pregnancy bleeding, ovarian cancer risk (1:1000) and increased breast cancer  risk for 
BRCA1/2 mutation carriers (El-Toukhy, 2014a; El-Toukhy, 2014b; Källén, 2008; 





        
Fig. 1: Timeline for a typical PGD treatment cycle (Khalaf & Grace, 2014) 
 
On day 14 to 16, oocytes are retrieved under anaesthesia (Fig 1). At the same time, 
semen is collected and in vitro fertilization takes place through intra cellular semen 
injection (ICSI) to avoid supernumerary semen contamination (Fig 2) (El-Toukhy, 
2014b). A biopsied sample is collected from fertilised embryos either at day three 
(blastomere) or day five or six (trophectoderm of the blastocyst) (Fig 2).  The latter is 
thought to be less traumatic to the cell and, as more cells can be removed than with a 
blastomere biopsy, provides more genetic material to test.  As a result, the majority of 
centres have modified their protocol to include blastocyst trophectoderm biopsy. 
(Kuliev & Rechitsky, 2015).  Healthy embryos will be implanted into the mother’s 
uterine under ultrasound guidance. Surplus unaffected embryos can be cryopreserved 






     
Fig. 2: Illustrative Procedure of PGD (Tur-Kaspa, Jeelani & Doraiswamy, 2014) 
 
2.2.3. Indications for PGD and technology used 
PGD can be provided for autosomal and sex linked disorders where mutations can be 
single base pair substitutions, insertions, or deletions or even large deletions or 
insertions and trinucleotide repeat expansions (Ben-Nagi et al., 2016). Different 
techniques may be required depending on the targeted mutation or the purpose of 
PGD-IVF (Brezina et al., 2012; El-Toukhy, 2014a). 
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2.2.4.   PGD for chromosomal anomalies 
If the target is avoidance of chromosomal aneuploidy or unbalanced chromosomal 
product, FISH is the most suitable technique (Brezina et al., 2012). Parents carrying a 
chromosomal rearrangement can have a reciprocal translocation, Robertsonian 
translocation, pericentric inversion or a paracentric inversion (Brezina et al., 2012). 
According to ESHRE data XIII  60% of tested chromosomal rearrangements were 
reciprocal translocations and 28% were Robertsonian translocations (De Rycke et al., 
2015). Carrier individuals are healthy and generally have no health concerns. These 
individuals are however at risk of producing gametes with unbalanced chromosome 
numbers which may result in infertility, live-births with congenital anomalies or 
developmental delay, multiple miscarriages or stillbirths (Brezina et al., 2012; El-
Toukhy, 2014a). PGD centres under ESHRE have reported the least viable embryos 
are those from parents who carry a reciprocal translocation (De Rycke et al., 2015). 
FISH is also used to screen for aneuploidy (PGS) in couples with infertility; recurrent 
miscarriage or advanced maternal age where both parents have a normal karyotype. In 
these cases PGS is used in an attempt to improve implantation rate (Brezina et al., 
2012). Despite the above mentioned advantages of FISH, the technology has 
limitations, including the possibility of culture failure, hybridisation failure and the 
inability to differentiate between unbalanced rearrangements unless specifically 
targeted with a spectrum of probes (Brezina et al., 2012; Kuliev & Rechitsky, 2015).  
Recently, the development of microarray technology has allowed aneuploid embryos 
to be excluded and is available in most IVF centres (fig 2) (Ben-Nagi et al., 2016; 
Flinter & Stewart, 2014). Microarray (PGS) allows screening of all chromosomes and 
can identify complex rearrangements in addition to aneuploidy (Scriven & Ogilvie, 
2014). Microarray (PGS) is done either through comparative genomic hybridization 
(aCGH) or through single nucleotide polymorphism (SNP) hybridisation. The two 
techniques are distinctly different: SNP array provides dense genotyping while aCGH 
provides a ratio between a labelled reference DNA and the tested DNA (Brezina et al., 
2012; Scriven & Ogilvie, 2014). While array CGH cannot differentiate ploidy status, 
SNP array can identify haploidy, triploidy, diploidy and uniparental disomy (UPD) 
plus regions of loss of heterozygosity (Repping, Mastenbroek & Scriven, 2014). In 
addition, SNP array is able to identify clinically relevant deletions and duplications 
that can be missed through aCGH or FISH. The disadvantage of SNP array is the high 
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monetary and time (30 to 40 hours) cost of the technique when compared to aCGH 
(12-15 hours) (Brezina et al., 2012). 
2.2.5. PGD for single gene disorders 
Single gene mutation is most likely to occur in autosomal recessive and dominant 
disorders (El-Toukhy, 2014a). In autosomal recessive conditions, the couple is healthy 
but are carriers for a disease with a recurrence risk of 25% while for the dominant 
disorders, one parent is affected and the risk of having an affected child is 50% (Ben-
Nagi et al., 2016). Testing for a monogenic mutation can be done via direct sequencing, 
genotyping or SNP array (El-Toukhy, 2014a; Ben-Nagi et al., 2016). More than 300 
monogenic disorders have been tested for PGD. The most frequently tested conditions 
are cystic fibrosis, the haemoglobinopathies and myotonic dystrophy (Fig 3) (Harper 
et al., 2012; Kuliev & Rechitsky, 2015). However, conditions that are often tested in 
western populations may not be common in other countries, especially in the Middle 
East where rare autosomal recessive disorders are more frequently found (Bittles & 
Black, 2010; Hamamy, 2012). Optimisation for these rare (novel) mutations remains 
a challenge and can reduce the opportunity for consanguineous families to embark on 
PGD. Another consideration for families undergoing PGD for monogenic diseases is 
the fact that a healthy embryo can still not be guaranteed due to the risk of birth defects 
such as chromosomal anomalies that are unrelated to the condition being tested.  
 




The common technical limitations of PCR are exacerbated in PGD due to the limited 
sample size Errors of diagnosis have been reported. Analysis of ESHRE data identified 
12 misdiagnosed cases over a period of ten years; 10 of them with monogenic 
autosomal disorders such as B-thalassemia, Charcot Marie Tooth and myotonic 
dystrophy (Harton et al., 2011a; Kuliev & Rechitsky, 2015; Wilton et al., 2009) and 
two cases with X-linked disorders. Ten cases were identified following PND while 
two were identified after birth (Wilton et al., 2009).  
These errors were mostly linked to allele dropout (ADO). ADO occurs as a result of 
the failure of amplification of one or both alleles and results in a false negative result 
(Brezina et al., 2012; Ben-Nagi et al., 2016; Konstantinidis et al., 2015).  
Misdiagnosis can also happen as a result of failure of PCR amplifications and DNA 
contamination (Ben-Nagi et al., 2016; Konstantinidis et al., 2015). Limitations of 
sample size (biopsy of a single cell as occurs with blastomere biopsy) can increase the 
risk of amplification failure or ADO (Kuliev & Rechitsky, 2015; Wilton et al., 2009). 
Contamination of DNA can occur from maternal cumulus cells or paternal 
supernumerary sperm (Wilton et al., 2009). Harper et al (2012) collected data from all 
ESHRE centres over a ten-year period and reported the misdiagnosis rate for 
monogenic testing via PCR was 0.27% (Harper et al., 2012). As a result of the 
technique limitations of direct PCR, guidelines recommend that a second test is always 
done for confirmatory purposes. This may include either multiplex PCR or linkage 
analysis by using polymorphic markers in close proximity to the gene of interest 
(Thornhill et al., 2005; Wilton et al., 2009). Linkage analysis is however not always 
possible as it requires samples from other family members. Samples are not always 
obtainable due to the unavailability of individuals or the couple being unwilling to 
reveal their genetic status or their intention for PGD to family members (El-Toukhy, 
2014a).  
Karyomapping is a new technique developed and optimised through an array platform 
which integrates 300,000 SNPs (Konstantinidis et al., 2015). It allows for the diagnosis 
of more than one monogenic disorder and is capable of identifying chromosomal 
rearrangements (Ben-Nagi et al., 2016). Karyomapping’s main advantage is that it 
provides a single protocol applicable to a wide range of patients which reduces the 
time required for pre-PGD test optimisation (Konstantinidis et al., 2015). 
Karyomapping does however have imitations and it should be run in parallel with a 
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conventional PCR when a high degree of homozygosity is expected (as in 
consanguineous families), for genes with low SNP coverages (CFTR & SMN1) and 
genes in telomeric regions (Ben-Nagi et al., 2016; Konstantinidis et al., 2015). 
2.2.6. PGD for mitochondrial disorders 
Mitochondrial disorders are inherited either through nuclear DNA (thus follow an 
autosomal recessive mode of inheritance) or via mtDNA mutations which are 
transmitted through the maternal line only. The latter is associated with pleiotropic 
expression (variable phenotypes depending on the threshold of the mutation load on 
the tissue) and variable expression due to heteroplasmy (different amounts of mutated 
mtDNA versus normal mtDNA within the cell) (Nussbaum et al., 2007). The poor 
correlation between mutation load and the phenotype plus the uncertainty of which 
tissue carries a greater load of mutated mtDNA limits the scope of testing for PND and 
PGD. An option available to non-Muslim couples is oocyte donation fertilised by the 
male partner’s sperm (Bredenoord et al., 2009). Gamete donation is not allowed in 
most of the Islamic sects and would therefore not be an option for most Muslim couples 
(El-Hazmi, 2004). A recent development that may be allowed for Muslim couples 
includes nuclear genomic transfer from the carrier maternal oocytes to a surrogate 
nucleus-free oocyte to provide a biologically related embryo (Serour, 2013). However, 
the Fatwa has not yet been released and it is uncertain if this option will be accepted 
by the religion.    
2.2.7. PGD for HLA matching  
Other couples might consider PGD for the purposes of HLA matching to facilitate 
donor compatibility (saviour sibling) for an existing affected sibling in the absence of 
a well-matched family member or cord blood (Ben-Nagi et al., 2016; El-Toukhy, 
2014a). Combining HLA typing with genetic testing complicates the technical 
procedure and reduces the chances of identifying a genetically and HLA suitable 
embryo among the existing fertilized cells (Brown & Gaspar, 2014; El-Toukhy, 
2014b). This option raises several ethical concerns related to the fate of healthy 
embryos who are not HLA matched; the desire to have another child for the sole 
purpose of saving the affected child; complications of PGD/IVF with potential 
pregnancy failure; limitations of PGD and misdiagnosis rate (Ben-Nagi et al., 2016; 
Brezina et al., 2012). 
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2.3. PGD policy and regulations 
Following the expansion of the practice of PGD after 1990, there was a need to set 
regulations to control the newly developing reproductive technology (Roberts & 
Franklin, 2004). The Human Fertilisation and Embryology Act was established in the 
UK in 1990 after the birth of the first PGD child. It regulates the practice of creation 
and use of human embryos (including PGD), the use of donated gametes or embryos 
and their storage (El-Toukhy, 2014a). In 1997 the European Society of Human 
Reproduction and Embryology was established to construct best practice guidelines; 
to stimulate research in reproductive medicine; to enhance teaching and training; and 
to collect data on PGD, pregnancy and children born through IVF/PGD (De Rycke et 
al., 2015; Harper et al., 2012).  
The ESHRE PGD consortium has published collective data including ten years of 
experience from 57 PGD centres distributed in 29 countries (Harper et al., 2012). The 
participating centres are from Europe, North and South America, Asia, Africa, Russia 
and Australia (Harper et al., 2012). Among these centres were two from the Arab 
Middle Eastern countries (one centre from Jeddah, Saudi Arabia and one from Al-Ain, 
United Arab Emirates). The data included a total of 27,000 cycles, 5187 pregnancies 
and 5135 live born babies. Out of the reported cycles, 61% were for aneuploidy 
screening (PGS), 16% oocytes were tested for chromosomal disorders, 4% for X-
linked diseases, 17% for single gene disorders and 2% for social sexing (Harper et al., 
2012).  
PGD is prohibited in many countries, including Germany, Ireland, Switzerland and 
Italy (since 2003) due to ethical and religious concerns (Gourounti & Glentis, 2012). 
The religious influence has played a major role in the prohibition of embryo 
manipulation in some countries and permission in other countries. The new approach 
of polar body testing may facilitate PGD for X-linked disorders in restrictive countries 
as the polar body is not considered part of the fertilized egg according to Catholic 
religious law (Kuliev, 2012). Preimplantation genetic diagnosis (PGD) is not restricted 
by Islamic law, on the contrary, it is encouraged as it replaces the termination of an 
affected fetus which is prohibited in some sects (Atighetchil, 2007; el-Hazmi, 1999). 
However, few centres are available in Arab countries and none are available in Oman. 
Couples who would like PGD must travel abroad for the procedure. 
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2.3.1. PGD Success Rate and Limitations 
According to the statistics provided by ESHRE, the overall success rate of PGD is 22% 
and the misdiagnosis rate 2.2% (De Rycke et al., 2015; Gourounti & Glentis, 2012). 
The misdiagnosis rate may be attributed to a number of factors, particularly the limited 
sample size as only one or two blastomeres can be utilised for testing and a single cell 
biopsy cannot exclude mosaicism (more than one cell line) in an embryo at the 
cleavage stage (Brezina et al., 2012; Harper et al., 2012; Konstantinidis et al., 2015). 
It has been reported that 40- 60% of embryos at cleavage stage (day 3 after fertilisation) 
are mosaic which increases the risk of false diagnosis (Harton et al., 2011b; Kuliev & 
Rechitsky, 2015). As mentioned, most PGD centres have moved to blastocyst biopsy 
(day 5 after fertilisation) where more cells (trophectoderm) can be biopsied to 
overcome the mosaicism issue and eliminate the risk of false negative/positive 
diagnosis (Harton et al., 2011b; Kuliev & Rechitsky, 2015). However, not all embryos 
reach this stage and biopsied embryos at blastocyst stage require cryopreservation or 
vitrification (instant freezing) to allow enough time to test before implantation has to 
occur. Polar bodies can also be used to overcome the sample limitations particularly 
when there is a concern for maternal chromosomal aberrations (Kuliev & Rechitsky, 
2015). Countries, such as Germany and Italy, who have strict regulations concerning 
the discarding of embryos, are able to use polar body testing.  
Other factors contributing to the failure rate of PGD include general IVF treatment 
challenges: the possibility of poor ovarian response to stimulation, failure of 
fertilization and poor embryo quality or absence of genetically suitable embryos for 
transfer (Brezina et al., 2012; Khalaf & Grace, 2014; El-Toukhy, 2014a). To ensure 
transparency, a couple should be provided with all the details related to the procedure 
and counselled by a specialist in reproductive medicine prior to PGD (El-Toukhy, 
2014a). Considering the misdiagnosis rate, a follow up PND is recommended. 
However, many couples may decline PND as they would not consider termination of 
an affected fetus (Lashwood, 2014). According to Lavery et al (2002), 63% of couples 
who achieved a successful pregnancy following PGD did not opt for confirmatory 
PND (Lavery et al., 2002). 
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2.4. Motivations for PGD 
2.4.1. Avoidance of recurrence risk and TOP 
PND is often considered by couples who may have experienced a pregnancy loss or 
had an affected child with a genetic disorder. In the event that prenatal testing indicates 
the fetus is affected the only option aimed at avoidance includes TOP. This can be 
associated with physical and emotional trauma compounded by grief and guilt (Katz 
et al., 2002). Therefore, PGD is often seen as an alternative to avoid the stress of PND 
and trauma of TOP (El-Toukhy, 2014a). Most studies report that couples prefer PGD 
to TOP which is often against their moral, religious or cultural beliefs (Karatas et al., 
2010a). Other families who have experienced previous termination of an affected 
pregnancy consider PGD to avoid a second termination (Karatas et al., 2010b; van Rij 
et al., 2011). 
Many studies have investigated the attitudes, experiences and motivation for 
undertaking PGD in western countries (Australia, UK, Spain, Sweden and USA) 
(Cunningham, Goldsmith & Skirton, 2015; Hershberger et al., 2012; Hershberger & 
Pierce, 2010; Järvholm, Broberg & Thurin-Kjellberg, 2014; Karatas et al., 2010a; 
Karatas et al., 2010b; Katz et al., 2002; Kalfoglou, Scott & Hudson, 2005; Lavery et 
al., 2002). Very few explored motives and attitudes toward PGD in Muslim and Arab 
groups (Saudi, Lebanon and Malaysia) (Alsulaiman et al., 2010; Alsulaiman & 
Hewison, 2006; Farra et al., 2008; Olesen, Nor & Amin, 2015) and none have been 
conducted on Omani families. 
Katz et al (2002) evaluated the range of moral and social concerns prior to undertaking 
PGD in Australian couples with three different obstetric and genetic histories (PGD 
for single gene, PGD+ PGS for aneuploidy screening and for IVF due to infertility 
issues). The majority - 95% of participants - found PGD/IVF acceptable and the 
discarding of embryos to be less harmful and morally more acceptable than terminating 
an affected pregnancy (Katz et al., 2002). A similar study was conducted on Arab 
Muslim Lebanese mothers of affected children with thalassemia. The study identified 
that 68% of participants felt that PGD was more favourable than PND for religious 
reasons (Farra et al., 2008). More than half of the participants (58%) consider the main 
advantage of PGD to be avoidance of termination (Farra et al., 2008). Likewise, Van 
Rij et al (2011) reported that 53.4% of couples out of a cohort of 264 referred for PGD 
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in The Netherlands favoured PGD (van Rij et al., 2011). The experience of one or more 
miscarriages, the loss of an affected child and the absence of (acceptable) alternatives 
for the female partner positively contributed to PGD intention (van Rij et al., 2011). 
Similar findings were identified among Malaysian patients considering PGD (Olesen, 
Nor & Amin, 2015) and Australian women (Karatas et al., 2010b). 
Jarvholm, Broberg and Kjellberg.K (2014) explored the psychological and health 
system considerations that influenced Swedish men and women’s PGD decisions 
(Järvholm, Broberg & Thurin-Kjellberg, 2014). They observed three themes of 
decision-making; related to self; related to the child and related to the society. In 
relation to self; an affected parent would consider PGD in order to have a better life 
for their children. The intention of reducing the burden on family or siblings by 
preventing the birth of an affected child was a common reflection among the 
participants. Those that had experienced termination found this was a key reason to 
undergo PGD (Järvholm, Broberg & Thurin-Kjellberg, 2014). Despite the stressful 
situation, some were able to think of the impact on others and the cost burden on the 
society (Järvholm, Broberg & Thurin-Kjellberg, 2014).  
Alsulaiman et al (2010) explored the attitudes towards PGD among a group of Saudi 
Muslim couples who had affected children with haemoglobinopathies. The study 
reported different attitudes among individuals who experienced genetic disorders 
(haemoglobinopathies and deafness) as compared to a control group of individuals 
undergoing IVF (Alsulaiman et al., 2010). Eighty-nine percent of the individuals who 
had a history of a genetic disorder were enthusiastic about PGD and had no concerns 
about the technical limitations. For half of these individuals confirmatory PND would 
have been considered if PGD was successful while only 18% of the IVF group found 
it acceptable. The difference among the PGD and IVF groups related to different 
perceptions and attitudes which could be correlated to "the chief aim of the genetic 
groups was probably to have a healthy child, rather than to avoid miscarriage of a 
particular pregnancy" (Alsulaiman et al., 2010; Lashwood & Say, 2014). Similar 
findings have been identified by other studies conducted on western populations (De 
Krom et al., 2015; Katz et al., 2002; Lashwood & Say, 2014). 
Couples appear to undergo a conceptual framework composed of cognitive appraisal, 
emotional responses and moral judgments when considering PGD (Hershberger & 
Pierce, 2010). These decisions are influenced by success rate, procedure risk, financial 
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costs and time while emotional responses capable of influencing the decision-making 
process may include regret, guilt, shame, sadness and despair (Hershberger & Pierce, 
2010).  
2.4.2. Emotional and psychological experience of PGD 
Different studies report the PGD journey as "emotionally draining" (Cunningham, 
Goldsmith & Skirton, 2015). Lavery et al (2002) reported that 41% of their cohort 
found the treatment cycle to be extremely stressful (Lavery et al., 2002). 
In a systematic review of literature related to the psychological and broader 
psychosocial impact of PGD, Karats et al (2010) confirmed the psychological and 
psychosocial impact of PGD (Karatas et al., 2010a).  
After then, Karatas et al., (2011) measured the level of anxiety and depression using a 
validated measure on a cohort of 50 women (Karatas et al., 2011). Results identified 
that anxiety and depression levels fluctuated during the PGD cycle and were highest 
following embryo transfer and pregnancy testing irrespective of a negative or positive 
outcome (Karatas et al., 2011). Similar findings were reported by Lavery et al., (2002) 
and Alsulaiman et al (2010) and karatas et al (2010b) where participants identified the 
pregnancy test to be the most stressful part (Alsulaiman et al., 2010; Karatas et al., 
2010b; Lavery et al., 2002).  
However, some PGD users find the time prior to implantation as stressful as post 
implantation in order to identify the availability of unaffected embryos. Negative 
results were reported to cause and acute disappointment and distress (Karatas et al., 
2010b). 
In a study by Roberts & Franklin (2004), participants expressed that PGD consumed 
their time, energy, attention and money (Roberts & Franklin, 2004). Although the 
participants felt fortunate to have the choice of PGD, the decision-making process was 
complex and required careful consideration of social and personal issues (Roberts & 
Franklin, 2004). Such a stressful life decision can impact on a couple’s relationship 
(Lashwood & Say, 2014). Lavery et al., (2002) reported that one third of the families 
experienced a negative effect on their relationship while for another third a positive 
effect was identified (Lavery et al., 2002) .  
Drazba et al (2014) focused on the psychological and financial impact of PGD and 
identified that these factors could complicate the PGD decision making process 
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(Drazba, Kelley & Hershberger, 2014). The study by Roberts & Franklin (2004) and 
that of Olesen, Nor & Amin (2015) emphasised the financial burden reported by PGD 
consumers (Olesen, Nor & Amin, 2015; Roberts & Franklin, 2004). 
Despite the stressful and negative emotions associated with PGD, some studies have 
highlighted the positive effects including the relief (Roberts & Franklin, 2004) and 
hope (Karatas et al., 2010a; Karatas et al., 2010b)  when arriving at the PGD clinic. 
2.5. PND and PGD perspectives in Islam 
Despite the fact that there are different sects in Islam, termination of an affected 
pregnancy is prohibited by the majority. Sharia’ in Islam is the word given to the 
perfect divine Islamic Law and is derived from the Holy Quran, Prophet Mohammed’s 
opinions and sayings (Sunna or Hadith) (Atighetchil, 2007) and agreed opinion and 
analogy of Islamic scholars “which is the intelligent reasoning, used to rule on events 
not mentioned by the Quran and Sunna, by matching against similar or equivalent 
events ruled on” (Serour, 2013). Islam has many sects with minor differences (Sunna, 
Shi’a and Ibadism which is a conservative form of Sunna but closer to Shi’a). Omani 
Muslims are mostly Ibadism and Sunna while Shi’a present as minorities in some 
colonies of communities (U.S. Department of State, 2010).  
Two main Fatwa’s (Islamic decrees) are derived from the interpretation of the timing 
of the ensoulment period. One Fatwa, embraced by most of the Islamic scholars, at the 
Islamic Fiqh Academy, describes the breath of ensoulment to occur 120 days after 
conception and therefore would permit TOP up to 120 days of gestation (Atighetchil, 
2007; Bruwer et al., 2014). The other Fatwa, which is followed by the Omani Grand 
Mufti (Highest Islamic scholar), believes that an embryo is a living human once a 
pregnancy is confirmed and would not permit TOP at any stage unless continuation of 
pregnancy could harm the mother's physical or mental health (Atighetchil, 2007; 
Bruwer et al., 2014). Islam is the predominant religion in Oman and plays a major role 
in Omani’s life and sociocultural beliefs (U.S. Department of State, 2010). The law in 
Oman states that Islam is the basic state of religion and Sharia’ is the basis of the 
religious legal system (Rajab, Al Rashdi & Al Salmi, 2013). Both Fatwa are recognised 
by Omani Muslims, however the official law in the country follows the Fatwa of the 
Grand Mufti of Oman. Consequently no hospitals in Oman are able to offer TOP 
(Bruwer et al., 2014) and couples have to travel abroad for termination which further 
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burdens the family emotionally and financially. Thus, PGD offers an alternative 
reproductive option for those who do not consider PND with TOP to be a preventative 
option.  
In Islam, PGD is allowed when performed by an embryologist who is aware of the 
Islamic regulations for handling human embryos. Individuals from whom the egg and 
sperm are retrieved must have a recognised Islamic marriage, live together and be alive 
(Atighetchil, 2007; Eskandarani, 2009). This permission interpreted as PGD does not 
conflict with God’s desire and wish, therefore, the technology used to select embryos 
is not considered a modification of God's creation (Alsulaiman & Hewison, 2006). 
Micromanipulation during the IVF procedure is allowed to overcome infertility issues 
(Atighetchil, 2007; Eskandarani, 2009). Furthermore, freezing of embryos, sperm, 
eggs, ovarian and testicular tissue is permitted in Islam providing that it will not be 
used for a different marriage, for donation or for surrogacy (Atighetchil, 2007; 
Eskandarani, 2009).  
Although PGD can serve as a reproductive substitute in most Islamic countries where 
TOP is not an option, few PGD centres are available in the Arab and Muslim countries 
(Atighetchil, 2007; Eskandarani, 2009). Saudi Arabia, United Arab Emirates, Iran, 
Malaysia and Turkey have established PGD centres while others like Jordan have a 
satellite PGD service in which IVF is done locally and the zygote biopsy is tested in 
an international centre for assays such as microarray (Eskandarani, 2009; El-Toukhy, 
2014a).  
Cryopreservation for healthy embryos is allowed in Islam under some restrictions; the 
marriage has to be ongoing; both couples need to be alive and the embryos may not to 
be used for another couple (Atighetchil, 2007; Serour, 2013; Serour, 2008). Couples 
are allowed to donate excess embryos for research providing informed consent is 
signed. This was confirmed in 2007 by different Muslim scholars who encourage using 
embryos for the development of knowledge for the advantage of humans. However, 
donated embryos have to be used before day 14 after fertilization (not to be allowed 
for further embryonic stages development) and may not be implanted in a woman’s 




2.6. Health care system in Oman 
Oman; officially the Sultanate of Oman; is an Arabian country located in Southwest 
Asia on the South Eastern coast of the Arabian Peninsula bordered by the United Arab 
Emirates, Saudi Arabia and Yemen (Rajab, Al Rashdi & Al Salmi, 2013; World 
Population Review, 2016). The majority of the Omani population consists of Arabs, 
ethnic Balochis (from Baluchistan/ Pakistan), ethnic Lurs (From Iran), Swahilis (East 
African), Hindus and Mehri (from India) (World Population Review, 2016).  
Health care in Oman is provided free of charge to all Omani citizens. There are more 
than 200 primary health centres, 50 secondary regional hospitals with specialised care 
distributed throughout the country and five main tertiary hospitals (Rajab, Al Rashdi 
& Al Salmi, 2013). A genetic service is integrated in two main centres; the National 
Genetic Centre under the ministry of health and the GDM under SQUH. Each of the 
centres consist of a clinical genetic team and diagnostic laboratories for cytogenetics 
and molecular genetics. However, as the molecular laboratory associated with the 
GDM clinic is underdeveloped, the majority of tests are outsourced to overseas 
diagnostic laboratories. The cost for molecular genetic testing is financed by the 
government.  
2.7. PGD procedure in Oman 
No PGD services are available within Oman and families considering PGD have to 
travel to neighbouring countries such as United Arab Emirates, Saudi Arabia, Jordan, 
Iran, Turkey or the United Kingdom (UK). Families with a molecularly confirmed 
genetic diagnosis are offered genetic counselling at the GDM clinic and reproductive 
options aimed at the prevention of disease recurrence are discussed. These options 
include premarital genetic testing and, for those who are already married, PND and 
PGD.  The majority of families in Oman avoid PND with the option of TOP due to 
moral and religious beliefs and thus prefer PGD. However, PGD is expensive and this 
contributes to a decreased uptake of this preventative measure. Prior to 2015, families 
who had no living healthy children were eligible for full coverage of the cost of one 
PGD-IVF cycle. Following budget constraints in 2015 all families interested in 
pursuing PGD, even if previously eligible for funding, have to cover the costs 
themselves. Although these families are no longer financially covered, the process of 
embarking on PGD is still facilitated by the clinic. If governmental financial strategy 
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integrated PGD services, this could be cost effective by alleviating expenditure on the 
medical care provided for an affected child (Tur-Kaspa et al., 2010). 
To date, 33 families have requested PGD through the GDM service. The role of the 
genetic counsellor, in addition to the genetic counselling and psychosocial support, 
involves preparation of the administrative work including communication with the 
PGD centres, counselling and consenting the couple for the procedure. In addition, the 
collection and shipment of requested samples for pre-PGD test optimisation is handled 
by the counsellor. On average the procedure can take as long as 12 to 18 months before 
a cycle is started.  
The GDM clinic refers patients to three centres. These centres have been selected as 
the embryologists are licensed, the laboratory is accredited, prices are competitive and 
centres are within an Arabic Muslim country. One centre is in Amman in Jordan and 
two in the United Arab Emirates (one in Abu Dhabi and one in Dubai).   
The cohort in this study received genetic counselling in the GDM clinic for a minimum 
of three counselling sessions lasting on average one hour per session. The couples had 
also been referred to the infertility team at SQUH and seen for infertility investigations. 
Counselling was also received at the PGD centre. Despite extensive counselling, it is 
not uncommon to find that individuals perceive success rates as higher than the actual 













Chapter 3. Methodology   
3.1. Method and Instrumentation 
This chapter will describe the methodological process of the research. It will include a 
discussion of the sampling method used, instrumentation, data collection and analysis. 
The chapter will conclude with a description of the measures taken to ensure validity 
and trustworthiness and ethical considerations. 
3.2. Research Design 
As described in chapter 2, minimal literature exists on the experiences of families 
undergoing PGD in Arab and Islamic populations (Alsulaiman & Hewison, 2006; 
Farra et al., 2008; Eskandarani, 2009) and to date no published research exists on this 
topic for Omani families. The research design was therefore selected to allow for an 
in-depth understanding of the main research question - the experience of Omani 
families undergoing PGD (Creswell, 2012; Macfarlane, 2014). Hence, this study 
utilised a qualitative, descriptive, phenomenological approach. Qualitative methods, 
in contrast to quantitative methods, are able to provide insight into the individual’s 
thoughts and perceptions and are not concerned with exploring cause and effect 
relationships (Macfarlane, 2014). This particular qualitative research paradigm is 
defined as a study in which the researcher attempts to understand a complex 
phenomenon based on a perspective that individuals’ lived experience is a valuable 
data source (Creswell, 2012; Ellis et al., 2008; Macfarlane, 2014).  
The approach uses an interpretive framework to enable the researcher to explore the 
experiences of the participants so as to uncover meaning and generate understanding 
(Lapan, Quartaroli & Riemer, 2012). The qualitative researcher immerses him/herself 
in the data in order to view the meaning of the articulated experience through the eyes 
of the participants (Lapan, Quartaroli & Riemer, 2012; Macfarlane, 2014). 
Phenomenology has also been described as "an approach that focuses on how life is 
experienced" (Denscombe, 2003). Furthermore, it does not primarily investigate the 
cause of the problem, but rather investigates how individuals experience the problem 
(Denscombe, 2003). This approach is best suited to the research question as it can 
provide insight into human experience through the use of dense descriptions provided 
by the individuals affected by the phenomenon under study (Baillie, 2015).  
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A cross sectional design was utilized which meant that information from participants 
was captured at one point in time. Although this meant that changes over time would 
not be identified, as in a longitudinal study, the limited resources and time available for 
the study made this an ideal approach (Creswell, 2012; Denscombe, 2003). 
3.3. Population and Sampling Method 
The GDM unit has facilitated 33 requests for PGD cycles since the inception of the 
service in 2014. Three families have achieved a successful pregnancy -  two of them 
from the first PGD cycle, and the third after the second cycle. Four families have 
undergone multiple PGD cycles without achieving a successful pregnancy and four 
families' plans were interrupted by a spontaneous conception. The remaining 22 were 
in different stages of the PGD process but have not yet reached the implantation phase.  
The researcher identified eligible families from the GDM PGD database and purposive 
sampling was used to recruit individuals that lived in close proximity (less than 200 
km from GDM). Purposive sampling allows for the identification and selection of 
information-rich cases related to the phenomenon of interest (Creswell, 2012). 
Individuals were selected on the basis of being easily accessible and willing to 
participate (Denscombe, 2003). According to Denscombe (2003), from a group of 
equal samples, it is reasonable to select the participant who is available first and in 
closer proximity to the researcher (Denscombe, 2003). 
To obtain broadest range of information, the researcher looked for variable samples 
that might offer contrary opinions and evidence as this would facilitate in-depth study 
while avoiding any appearance of biases (Patton, 1990).  Bringing people of the same 
background and experience together to participate in in-depth interviews enables the 
researcher to shed light on the major issues affecting them (Patton, 1990; Denscombe, 
2003). 
Macfarlane et al (2014) propose that "8-13 participants in individual interviews are 
typically sufficient for saturation" (Macfarlane, 2014). Once saturation is reached, no 
new description or explanation arises from further exploration and increasing the 
sample size only results in duplication or redundancy of ideas (Creswell, 2012; 
Macfarlane, 2014; Patton, 1990). Furthermore, larger samples do not necessarily 
enhance the research as they may lack the depth and richness of a smaller group 
(Creswell, 2012). The target for this study was therefore to recruit 10 couples in order 
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to achieve data saturation (Macfarlane, 2014). Although all families were enthusiastic 
to participate, many were unable to commit to an interview due to their ongoing PGD 
procedures and/or family circumstances related to the needs of their affected children. 
Thus, considering the time constraints associated with a mini-dissertation the number 
was reduced to eight couples (14 interviews; two female partners could not commit 
due to health or social issues). However, it was felt that data saturation was achieved 
where no new themes identified in the last two interviews.  
In this study, each partner of the Omani couple was interviewed separately to enable a 
comparison of the PGD experience from both the female and male perspectives. 
Although several studies have assessed perspectives, attitudes and experiences 
surrounding PGD, they have been limited to female participants (Farra et al., 2008; 
Karatas et al., 2010b; Wah Hui et al., 2002). Only a limited number of studies have 
considered the couple’s perspective, but in these studies, information was obtained 
from joint interviews (Alsulaiman et al., 2010; Järvholm, Broberg & Thurin-Kjellberg, 
2014; Lavery et al., 2002). 
3.3.1. Setting 
When an individual is requested to discuss sensitive issues, a private venue is more 
likely to result in a true representation of the situation (Lapan, Quartaroli & Riemer, 
2012; Macfarlane, 2014). Interviews therefore took place in the participants’ homes or 
a private venue of their choice. Six of the eight families preferred to be seen in a private 
room at the GDM clinic before or after one of their frequent hospital appointments and 
two families were interviewed at home. 
The researcher obtained the data for her study during face-to-face interviews. Face-to-
face interviewing is time intensive as it focuses on extended interaction, and requires 
transcription of the interview material, as well as familiarisation with the data and the 
coding process (Lapan, Quartaroli & Riemer, 2012; Macfarlane, 2014). Lapan et al 
(2012) describes this method "as one that allows for a collection of richer data with 
nuance" (Lapan, Quartaroli & Riemer, 2012). It additionally allows for the observation 





3.3.2. Inclusion criteria 
 Individuals with a molecularly confirmed genetic diagnosis identified in the 
proband or family member 
 Individuals counselled about the genetic diagnosis and option of PGD 
 Individuals enrolled in the PGD request process (any stage of process) 
 Individuals willing to be interviewed and audio-recorded by the researcher 
 Individuals accessible for a personal interview 
3.3.3. Exclusion criteria  
 Individuals who have previously undertaken PGD without been counselled or 
seen by the GDM team 
3.4. Measurement Instruments 
3.4.1. Interviews 
A semi-structured interview schedule including the researcher’s observations was used 
to gather data for the study (Appendix C) (Creswell, 2012; Lapan, Quartaroli & 
Riemer, 2012; Macfarlane, 2014). 
The researcher started the interview by providing the participant with an information 
sheet, before discussing the aims and objectives of the research and answering any 
queries. The consent form was then discussed with an explanation about the research, 
the need for audio-recording, potential publication and the strategy to maintain 
anonymity and confidentiality. The interview began with closed-ended questions 
about demographics. These basic questions helped to establish some rapport with the 
participant prior to discussing more sensitive issues (Patton, 1990; Denscombe, 2003). 
Open-ended questions within the interview schedule were grouped into six main 
categories. These included motivations for PGD and how participants learnt about the 
procedure; how the decision was made and the impact of the decision on the couple's 
relationship and lifestyle. The researcher also explored the religious and social impact 
of the couple's decision based on their population background. The last question dealt 
with the availability and accessibility of support for couples undertaking PGD. As the 
researcher gained experience with interviews, she was able to pick up on issues as the 
participant discussed them. If the answer to the main question was insufficient, the 
researcher enquired further with open-ended questions. Prompts were additionally 
used to clarify responses or to facilitate greater exploration of a particular topic when 
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required. Probes were included to enable the researcher to cover each topic in enough 
depth before the participant moved onto the next topic. As suggested by Denscombe 
(2003), probes were handled in a sympathetic and subtle manner (Denscombe, 
2003). Validity of the questions, probes and/or prompts were reviewed by the 
researcher’s supervisors to ensure they were understandable and neutral.  
The order of the questions in the interview schedule varied according to the trend of 
conversation, however the same interview schedule was used for all participants to 
explore the story of their PGD experience (Alsulaiman et al., 2010; Hershberger et al., 
2012; Katz et al., 2002; van Rij et al., 2011). The researcher used other data sources, 
such as the GDM database and hospital records, to collect and verify demographic 
details, family history of recurrence, age of the couple and number of affected versus 
living healthy children.  
3.4.2. Audio recording 
A digital recording device was used to record the interviews for documentation and 
transcription. This also allowed the researcher to wholly engage with the participants 
instead of having to write down their answers. Audiotaped digital files were dated and 
labelled with codes and the participant’s names were kept separate from both the tapes 
and interview schedules. Only the researcher had access to these, thus preserving 
participant confidentiality. The recordings were directly translated from Arabic to 
English after each interview by the researcher who is fluent in both Arabic and English. 
Any non-verbal cues, identified during the interview, such as facial expressions or 
gestures, were noted during the discussion and written down immediately after the 
interview from the field notes. 
3.5. Procedure 
3.5.1. Testing interview 
A test interview was conducted as a role-play scenario with two Arabic speaking 
colleagues and observed by the co-supervisor. This allowed the schedule to be refined 
and identified changes needed to improve clarity. Furthermore, questions were tested 
for difficulty of comprehension, ensuring that data would be observable and 
measurable (Creswell, 2012). A second test interview was then undertaken with a 
participant who met the inclusion criteria. The interview schedule was adapted after 
these test interviews to aid the clarity of the questions and subsequently rechecked by 
36 
 
the researcher’s supervisors. As a result of the time constraints and limited participants 
available for interviewing during the study period, the data from the second test 
interview was included in the write-up. However, a follow-up interview was arranged 
with the participant to supplement the previously collected data. The length of the 
interviews were between 50 and 60 minutes as assessed through the test interviews.  
3.5.2. Recruitment 
Participants were selected on the basis of having undergone experiences about which 
the researcher wanted to gain insight and were selected from the GDM database. 
Potential candidates meeting the inclusion criteria were invited to participate in the 
study telephonically or during their clinical visit. The purpose of the research and 
expected length of interviewing was explained and interested participants were given 
the choice of place and time for an interview. Every individual invited to participate 
in the study consented to interviewing, audio-recording and potential publication of 
anonymised data. 
3.5.3. Implementation of interviews 
The researcher conducted every interview personally during the months of February 
to May in a private venue of the participant's choice. Where both members of the 
couple were available, separate individual interviews were conducted to exclude 
partner pre-dominance (Hershberger et al., 2012). However, the researcher had to 
consider meeting the couple together, as opposed to interviewing the husband 
separately, if the interview was conducted in the home setting. This was to respect the 
cultural and religious aspects applying to a female researcher when interviewing a 
male participant. By Islamic law, a woman is not allowed to be in a closed or isolated 
area with anyone other than her father, brother, husband, son, uncle, grandfather/ 
grandchild and nephew. In essence the people whom she is forbidden to get married 
to (Atighetchil, 2007). However, only one couple had been interviewed together.  
All interviews were conducted in Arabic, the first language of the participants. If any 
distress was experienced by the participants during the discussion of their experience 
of PGD, they were given the option of further counselling with a qualified genetic 
counsellor or clinical geneticist.  
A total of 14 interviews were conducted to reach data saturation. Eight males and six 
females were interviewed. Two females, of the eight couples, could not be interviewed 
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as a result of social or medical reasons despite rescheduling the interview three times. 
Due to the time limitations associated with the study and after discussion with the 
supervisors it was decided to exclude these individuals from the interviewing process. 
The majority of interviews were conducted in a private venue in the clinical setting 
(85% of participants; 12/14) while two participants (15%; 2/14) preferred to be seen 
at their home. 
3.6. Data Analysis and Interpretation 
On average a one hour interview took four to six hours to transcribe and produced 
eight to nine pages of data. Transcription and translation was carried out by the 
researcher and this allowed for repeated listening and proof reading of the data. As the 
studied group was small and to maintain the confidentiality the researcher did the 
transcription and translation herself. The first seven transcripts were used as a guide to 
the initial recording. The researcher went back and forth between the transcripts and 
the audio records, which is ultimately the data, to refine the themes. The more the 
researcher listened to the audio-recordings the more familiar she became with the data 
enabling the comparison of translated transcripts to identify nuances (Yin, 2011).  The 
researcher continued with the re-listening during the interpreting, coding and theme 
identification phase.    
Data was analysed using thematic analysis. During this process the researcher 
analyses the data and interprets patterns of responses to bring order, structure and 
understanding to the mass of collected information (Braun & Clarke, 2006). Raw 
qualitative data by itself is not informative and certain steps are required to organise 
the collected information into meaningful and descriptive data. Creswell (2012) 
recommends several steps for thematic analysis. These include: 
- Reading the written transcripts several times and listening to the
recordings to obtain an overall feeling
- Identifying significant meaning linked directly to the experience
- Formulating meanings into clusters of themes
The collected themes can then be integrated into a thorough text description of the 
phenomenon (Braun & Clarke, 2006; Creswell, 2012). The researcher followed the 
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seven steps described by Colaizzi (1978) and integrated in Creswell's recommendation 
for data analysis (Edward & Welch, 2011). These steps are described as follow:  
1. Transcribe the participant's narrative descriptions from the audiotape (Multi 
steps of writing through different individuals can threaten the data by losing 
the original meaning (van Nes et al., 2010))  
2. Extract statements from the participant's narratives that are directly related to 
the phenomenon under study. Significant statements are numbered and 
assembled in a list 
3. Attempt to formulate more common statements or create a meaning of each 
statement   
4. Organise formulated statements or meanings into clusters of themes (groups of 
similar types) 
5. Develop comprehensive descriptions for the clustered themes 
6. Rigorously analyse the comprehensive description of the themes to identify a 
fundamental structure for the phenomenon 
7. Validate the essence of the phenomenon.  
Immersion in the data can help the researcher comprehend the meaning of the 
participant responses (Creswell, 2012).  As the interviews went on, the researcher 
could identify common words, events or ideas shared by participants (Step 2 of 
Colazzi’s approach). The initial coding procedure was guided by the literature and 
observations from clinical experience (Patton, 1990; Braun & Clarke, 2006). 
Commonalities and differences that were observed in patterns were then defined as 
themes (Braun & Clarke, 2006; Creswell, 2012). 
The researcher met regularly with her co-supervisor to review the identified codes 
during the interpretation and categorisation of the analysis phase. The emerging 
themes were also discussed and finalised with the supervisors. 
Quotes were included to substantiate participants’ responses. As all interviews were 
conducted in Arabic, the meaning of the sentence, rather than the exact wording, was 
included. This was done to ensure the meaning was not lost during the direct 
translation into English (van Nes et al., 2010). Although this process may mean that 
some of the authenticity is lost, it is more important to ensure the meaning of the data 
is conveyed to the reader rather than the actual words (Carpenter & Suto, 2008; 
Denscombe, 2003). However, to uphold validity, supervisor checks were included to 
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ensure that the interpretation did not alter the participant’s meaning during this 
process.  
3.7. Trustworthiness and rigour 
3.7.1. Validity 
Qualitative research requires different techniques to enhance rigour compared to the 
ones used in quantitative research. Rigour in qualitative research uses one or more 
validation procedures to ensure accuracy. These may include prolonged time in the 
field, member checking, validation, use of peer-review or external auditors and/or 
negative case analysis (Baillie, 2015; Creswell, 2012). 
This research used some of the suggested techniques, appropriate to the research 
design, to maintain validity. Data were validate by cross-checking the information and 
observing reactions or responses of patients seen but not participated in the study. A 
Different combination of data sources used for the study included interviewing, 
observations and analysis of the GDM database records. This technique describes the 
use of different methods of data collection, where the strength of one approach 
compensates for the weakness of another approach (Baillie, 2015).  
In order to establish external validity of the research, a rich description of the research 
methodology was ensured so that it could help the reader decide whether the research 
would be transferable to their setting or not (Beeson, 1997; Creswell, 2012). Many 
qualitative researchers are more meticulous about validity - "the degree to which data 
and interpretation fit with the situation" - than with generalisability (reproducibility 
and regeneration of the data in other contexts) (Lapan, Quartaroli & Riemer, 2012). 
The researcher additionally used rich description to support the development of a clear 
audit trial to provide a transparent and detailed account of the sampling method and 
sampling size (Baillie, 2015; Creswell, 2012). Thus readers can determine if the same 
research findings could be applied to reflect key concepts or experiences in other 
cohorts or situations. 
Peer review was used to ensure credibility and the researcher met with her supervisors 
on a regular basis to check the data collection and transcription. In addition, regular 
meetings also took place with the neutral co-supervisor during the analysis phase. This 
was undertaken to eliminate any bias in the interpretation and categorisation of the 
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data and content analysis and promoted confidence in the truth of the findings of the 
study. 
The content validity of the interview schedule was reviewed by the supervisor and co-
supervisor for the English version and by two Omani genetic counselling colleagues 
at the GDM clinic for the Arabic version. This ensured that the sequencing of questions 
was appropriate and easily comprehensible and understandable. The role-play 
conducted with the Omani GDM staff members could additionally serve to validate 
the translated interview schedule in terms of the sensitivity and reliability of the words 
used in the Arabic interview schedule.  
3.7.2. Reflexivity 
In qualitative research, the researcher is the main instrument for data collection and 
can potentially influence how data is collected and interpreted (Baillie, 2015). 
Therefore, reflexivity during the field work is of importance. Finlay (2002) described 
reflexivity as "a confessional account of methodology or as examining one’s own 
personal, possibly unconscious, reactions" (Finlay, 2002; Finlay & Gough, 2008). The 
focus is on exploring the dynamics of the researcher–researched relationship (Finlay, 
2001). Reflexivity can be a valuable tool to: 
 examine the perspectives of the researcher;  
 investigate personal interaction and interpersonal dynamics  
 create self- awareness of unconscious drives and hidden biases;  
 qualify external auditing;  
 examine the integrity of the research approach and interpretation (Finlay, 
2002).  
The researcher took field notes before, during and after each interview. A conscious 
effort was made to differentiate between the researcher's personal values and those of 
the participants and she obtained repeated affirmations from the participants related to 
the information that was heard. This ensured that the findings were as a result of the 
research and not related to subjectivity or personal bias (Denscombe, 2003). 
The researcher faced a professional challenge in her dual roles as a health care provider 
involved in counselling families through the lengthy PGD procedure, and as a 
researcher interested in uncovering meaning from their experiences and accessing their 
accounts of events she has not witnessed (for instance during the PGD procedure 
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abroad or at the family’s homes). As the researcher was heavily involved with helping 
the families with the PGD arrangements there was an assumption that, as rapport had 
already been established, there would be minimal obstacles to conducting the research. 
However, difficulties were encountered during the research. The first occurred during 
the initial telephonic contact inviting the selected individuals to participate in the study 
as calls were integrated with pending issues for the PGD arrangements (there was a 
risk of confusing the request as a requirement for the procedure). Therefore, the 
researcher had to alert the call recipient to separate the two distinctly different 
discussions. This also occurred during the appointment setting, where the researcher 
had to prioritise the research interviews due to the time limitations associated with the 
mini-dissertation. These concerns were discussed with the supervisors but are not 
unique in research. The same issues have been described as part of the experience of 
doing qualitative research at home which can be labelled as "switching on and off" or 
"entry and exit" of daily professional life and research (Nordquest, 2007). The 
researcher had to ensure that she did not take on the genetic counselling role during 
the interview as she had been involved in direct counselling or observation of the 
interviewed patients. To overcome this issue, an agreement was made with the 
interviewee to set up a counselling session if a need was identified during the 
interview.  On the other hand, the researcher had to take off the researcher hat while 
counselling couples that were identified as potential research participant. Awareness 
of the different roles of researcher and counsellor ensured that an ethical framework 
for dealing with this concern was established prior to the study. Thus the researcher’s 
professional activity did not interfere with the data-collection process and she was 
capable of maintaining the professional standards and codes of conduct of a practicing 
genetic counselling student. 
Families were excited and enthusiastic to participate in the research as most of them 
"had something to share with others". However, agreeing on an interview time and 
venue was also difficult. Most of the families had frequent hospital appointments for 
their affected children as well as for their PGD preparations. Some had ongoing 
unplanned spontaneous pregnancies and were emotionally traumatised at having to 
consider/plan for prenatal diagnostic testing. Others achieved a successful PGD 
pregnancy which required that the researcher had to see them for post PGD counselling 
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and referrals to other departments. All these factors played a role in the number of 
participants available to participate in the research study. 
3.8. Ethical Considerations: 
The research was approved by two ethical committees before the data was collected: 
College of Medicine and Health Science at SQU where the study was undertaken and 
UCT research and ethics department at UCT where the master’s program was under 
taken (HREC/REF: 009/2016 and SQU-EC.244/15 MERC 1215) (Appendix F).  
Participants were informed of the following points when invited to participate in the 
study: 
 Aims and objectives of the research study 
 Participation was voluntary 
 The participants were assured that they had the right to withdraw at any stage 
of the study with no impact on their current or future health care. 
Written informed consent was obtained for the interviewing and audio-recording 
process and all participants were over the age of 18 years and legally competent to sign 
consent. The consent forms are provided in Appendix E. 
Participant confidentiality was maintained. Transcripts of the interviews were coded 
with numbers and locked in a cabinet where only the researcher had access to the actual 
data. The interview recordings were kept after the transcription process as the 
researcher needed to re-listen to the data several times to maintain rigour of data 
analysis. The records were discarded after the analysis and theme identification phase. 
Maintaining anonymity was challenging in this group as the number of patients 
enrolled in PGD is small and the genetic conditions are rare. Therefore, in an attempt 
to maintain anonymity, the researcher provided select information in the table of 
demographics of the participants.  For example, the genetic conditions were grouped 
as neurodegenerative or metabolic rather than listing the exact conditions and the 
participants were coded as P1 to P14. In addition, the quotes were labeled as family 
and not participant and losses were described as “many” rather than stating the exact 
number.  It is acknowledged that this may affect the validity of the study but it was 
thought that this was the best compromise to being transparent and protecting the 
participant’s privacy. Participants were reassured that their data would remain 
confidential apart from possible future publication in a scientific journal, when names 
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or any identifiable characteristics would not be included. If distress was expressed 
during the interview, participants were referred for genetic counselling. 
3.9. Risk and benefits to subjects: 
Participants were informed that their confidentiality would be respected and data kept 
anonymous. As the researcher explored intimate and sensitive decisions, participants 
were assured that they had the right to choose to decline to answer any questions. In 
addition, early withdrawal from the study would not cause any harm or alter the 
provision of care. However, participation in the study would also neither benefit or 
privilege the individuals. All participants were treated equally and offered referral to 
counselling by a qualified genetic counsellor if potential harm or emotional distress 
was expressed. 
3.10. Strengths and Limitations of the Study 
As with all research this study has its own strengths and limitations and the details are 
discussed below: 
3.10.1.    Limitations 
 The use of a cross-sectional design meant that participants’ experiences
could not be assessed over a period of time. It is therefore possible that
certain views may have changed over time;
 Sample selection was believed to include the informative families who
experienced PGD. However, there could be a bias in selection as the
samples were chosen based on the researcher’s background and
knowledge of the families based on her previous interaction with the
participants;
 Although most of the invited candidates were willing to be enrolled in
the study, the researcher experienced difficulties recruiting more than
eight couples. The reasons related to frequent hospital appointments for
their affected children or for PGD investigation, ongoing pregnancy or
emotional distress due to failure of a cycle;
 Minimal literature was available on the experiences of PGD in Arab
and Muslim societies, particularly in Omani patients. Therefore, a
limited amount of data was available for comparison purposes.
44 
 
Comparison with non-Muslim and other ethnic groups was possible but 
may not have been as informative; 
 The researcher’s level of counselling skills could have missed salient 
points. 
3.10.2.   Strengths 
 Each interview was conducted by the researcher in a venue of the 
participant’s choice and in his/her first language; 
 Face-to-face interviewing is known to improve response rates; 
 Semi-structured interviewing is more flexible than a structured 
questionnaire and allowed participants the opportunity to express their 
personal views;  
 Audio-recording of the interview reduced researcher bias in reporting 
the articulated interview as it captured the exact words of the participant 
and allowed for re-visiting of the data; 
 Reflexivity of the researcher supported self-identification and was 
believed to reduce personal bias and subjectivity.  
The findings of the interviews will be presented and discussed in the next chapter. 
Validation for the findings will be presented with quotes from translated interview. 
The results will be contrasted to the findings in the literature to identify similarities 
and differences with other PGD users form other countries. The presentation of the 
analysis, findings and discussion are combined in Chapter Four. This format is 
customary in qualitative research (McMillan & Schumacher, 2001) and prevents 











Chapter 4. Results and discussion 
4.1. Introduction  
This chapter will describe the sociodemographic characteristics and reproductive 
history of participants. This study identified five main themes emerging from the data 
collected through interviewing couples who had experienced the process of PGD. 
Partners were interviewed separately; mostly on the same day. One couple was 
interviewed together (as discussed in chapter 3). Quotations from the participants’ 
interviews have been included to enhance the validity of the identified themes. Some 
participants mentioned their history and for confidentiality, information that does not 
add value on the study or would not decrease the validity of the data, has been removed 
from the quotations.  As discussed in chapter 3, translation for meaning rather than 
wording was conducted to reduce the chance of losing the nuances contained in the 
original meaning. The quotes used are therefore not verbatim. To maintain anonymity 
and ensure confidentiality, a code was assigned to each participant. The names of the 
disorders were not included as this is a small group of very rare disorders where 
individuals could be identified from this information (as explained in chapter 3). 
However, a general classification has been provided to offer the reader insight into the 
disease type and prognosis.   
4.2. Description of participants: 
All participants (n=14) were Omani Muslims of Arab descent who speak Arabic as 
their first language. Six couples out of eight families participated in the study. This 
section will describe participants in two separate tables; table (1) contains 
demographic information for each participant and is labelled with alpha-numerical 
code. Table (2) summarises the reproductive histories of all families. Separation of the 
tables was done to reduce identification of individuals by their reproductive history. 
4.2.1. Demographics  
The age of participants ranged from 26 to 41 years with an average of 36 years for 
males (26 - 41) and 33.5 years (range 28 - 37) for females. The majority (57%; 8/14) 
of the participants had completed a college degree or higher diploma certificate and 
have a full time job with an average household income of 24,900- 46,700 USD per 
annum. According to the National Centre for Statistics and Information (NCSI) of 
Oman, yearly statistics book: 2016, the average Omani household income is 37,000 
USD per annum (NCSI, 2016). Five (35.7 %) participants were school graduates in 
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full-time employment with incomes ranging between 15,500 and 23,800 USD per year 
(lower middle income) (NCSI, 2016). The only participant who did not complete 
schooling (for social reasons) runs a private family business generating an average 
income within the low income (11,444 – 15,588 USD annually).  
Since the PGD procedure is very expensive (10,400 – 18,000 USD), financial 
assistance for the intervention was required by the majority of participants. The cost 
of the procedure, excluding travelling expenses, was close to half the average annual 
income. The majority of participating families requested a financial grant but only five 
(62.5 %) were eligible (had no living healthy child) and successful in obtaining 
financial assistance from the government. The remaining three families (37.5 %) who 
financed PGD themselves were from a similar income category. They were not eligible 
for governmental funding as they had one healthy living child. Table 1 summarises the 
sociodemographic information of participants.  
Table 1. Sociodemographic information of participants (n=14) 
  Age Level of 
Education 





P1 37 School Neurodegenerative  0 1 
P2 36 College Neurodegenerative 1 1 
P3 41 College Neurodegenerative 1 1 
P4 28 College Metabolic  0 0 
P5 37 College  Chromosomal 
imbalance 
0 2 
P6 28 School Neurodegenerative 0 1 
P7 34 School Neurodegenerative 0 1 
P8 37 College Metabolic  1 0 
P9 26 School Metabolic  0 0 
P10 35 College Chromosomal 
imbalance  
1 3 
P11 40 College  Chromosomal 
imbalance 
1 3 
P12 37 College Metabolic  1 0 
P13 40 Did not 
complete 
schooling 
Neurodegenerative 0 3 
P14 34 School Chromosomal 
imbalance  




All families had at least one affected child with a lethal genetic disorder. Four families 
were at risk of having a child with an autosomal recessive neurodegenerative disorder 
(Aicardie Goutier, Warburg Micro syndrome and iron brain accumulation gyrate 
atrophy). Two families had a history of chromosomal imbalances due to a carrier 
parent (t (5:13) and t (15:18)). The remaining two families were at risk for an 
autosomal recessive metabolic disorder (Glutaric acid urea and hydrops fetalis due to 
a novel as yet unreported founder gene involved in metabolic / mitochondrial 
cardiomyopathology). The pregnancy-related history and clinical outcome is 
summarised in Table 2. 
Table 2. Summary of reproductive and PGD family history 
Reproductive health status of families No. of families/ 8 
Families with history of still birth/ miscarriage 2 
Families with a history of neonatal death 1 
Families with a history of early childhood death 2 
Families with a history of adolescent death 2 
Families never experiencing a loss 1 
Affected with autosomal recessive condition 6 
Affected with chromosomal imbalance 2 
TOP 2 
Approved for financial grant 5 
Completed PGD cycle 6 
PGD successful pregnancy  2 
Interrupted by natural conception  3 (2 never started 
a cycle) 
 
All the participating families were at different stages of the PGD procedure. Six had 
completed at least one cycle (75%) while two (25%) had not yet had a PGD cycle as 
they had conceived spontaneously before starting the IVF treatment. Another family 
had conceived spontaneously after several unsuccessful PGD attempts.  
Despite counselling families at risk and emphasising the need to utilise different 
methods of birth control, unplanned pregnancies occurred in three families prior to 
initiating PGD (one had experienced previous unsuccessful cycles). This meant that 
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PGD had to be postponed until after the birth of the child. One of the three families 
had a healthy term child, one had an affected child and the other was currently pregnant 
(uncertain status). None of the participants requested PND. Interruption of a PGD 
cycle by spontaneous pregnancy is a common occurrence (Lashwood & Say, 2014; 
Lashwood, 2014). 
4.3. Themes identified 
This section will discuss the themes emerging from the data collected through 
interviewing fourteen participants. Headings are organised according to the main 
theme and followed by the sub-themes. The themes were extracted by the researcher 
after reading the translated transcripts and re-listening to the audio-records several 
times (as described in chapter 3). Themes and sub-themes were validated by the 
supervisor and the co-supervisor. Themes are organised according to the stages of the 
PGD as experienced and reported by the participating families. The section headings 
describe themes as follows: the desire for healthy child; anxiety; unforeseen; secrecy 
and me and my partner. Excerpts from participants are used when appropriate to 
strengthen the argument and compared to the published literature when required to 
highlight any similarities or differences. Table 3 is a summary of the identified themes 
and sub-themes. 
 
Table 3. Description of themes 
Theme Sub-theme 
Desire for healthy child - Longing for a child (window of hope) 
- Can’t have another affected 
- Avoidance of TOP 
Anxiety “Taraqub”  
 
- Road to PGD 
- Waiting for exam results 
- She was not herself 
Unforeseen - Loss of intimacy and autonomy 
- Piece of me   
- Never expected a failure 
Secrecy  - PGD baby “Haram” 
Me and my partner - Impact on the relationship 
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4.3.1. Theme 1 
4.3.1. Desire for a healthy child 
In this study, the primary motive for undertaking PGD was related to a poor 
reproductive history. All participants embarked on the procedure of PGD based on 
their reproductive history of having an affected child or losing an affected pregnancy. 
Males and females agreed that the reproductive history was a primary reason for 
pursuing PGD. 
4.3.1.1.   Longing for a child (window of hope) 
All couples had between one and four affected children (Table 2.). Five families had 
no healthy living children before enrolling in PGD while three had only one healthy 
child. Patients who had experienced miscarriages or pregnancy losses were as 
motivated to undergo PGD as the couples who had lost children during infancy.  
Family 5 lost many affected children and expressed that the losses had motivated them 
to consider an alternative reproductive plan so that they could have a healthy 
pregnancy. 
” First time I heard about the treatment I was excited, it gave me a hope, a 
new hope, my main motive is that I don’t have many children now, I want to have 
children” (Fm5-M, lost affected term pregnancies, have one healthy child). 
Another family who presented with multiple miscarriages and affected full term 
children (with survival limited to one month) expressed the importance of PGD 
consideration for risk avoidance: 
“I think any mature adult parent who has a genetic disorder and knows about 
this option should consider it rather than having an affected child” (Fm6-M, 
multiple miscarriages, lost affected term children). 
Similarly, family 2 lost many affected children and found the option of PGD to be their 
only choice if they were to consider having more children. The family would rather 
avoid having future children than take the risk of having another affected child.  
 “Living without a child is better than bringing to life another affected child. 
Definitely PGD is the window of hope for me and my wife and we will not stop 
trying” (Fm2-M, one live child, lost many children, experienced a PGD cycle).  
50 
 
Religious beliefs were a major driving force in pursuing PGD for all 14 participants 
Having healthy progeny is particularly important in Islam as the main Islamic 
teachings encourage followers to maintain self, health, wealth, mind and progeny (El-
Hazmi, 2009). Many (n=5) quoted phrases from the Quran or Hadith (prophet 
Mohammed’s opinions) which say that having a large healthy family and many 
offspring is more favoured by God and the Prophet Mohammed who will be proud of 
them on the day of resurrection. This phrase was quoted by four males and one female 
participant.  
Messenger of Allah (peace be upon him) said, “Get marry and multiply, for 
I shall be proud of you in the day of resurrection”.  
One of the participants stated that he would like to proceed with a second PGD cycle 
as soon as financially possible although his wife was content with one healthy child 
after their first PGD. He expressed that this was hurtful to him as he would have liked 
to have had more children. However, he did report that this did not raise conflict in 
their decision making.  
“Children are the wealth of the life. I would like to go for another cycle as 
soon as financially afforded, but my wife does not. This hurts me due to my longing 
for many children” (Fm1-M, lost affected children, went through a successful PGD 
cycle). 
A small family size has a major psychosocial impact on many individuals from Middle 
Eastern and Muslim backgrounds due to cultural expectations and preference for 
having many children (El-Hazmi, 2004) and this was clearly observed in these 
families' motivations, as they reported the need to have more children.  
A participant with one healthy child, had gone through several pregnancy losses as a 
result of natural conception and experienced multiple PGD cycles expressed her desire 
to have many healthy children and be a mother   
“My desire to be a mother cannot stop for one child, I will continue at least 
for one more and then consider permanent sterilisation /…/Time passes and I 
understand that as I get older the risk increase to lose my eggs and have more 
syndromes like Down syndrome plus my main problem. This pushes me forward to 




Similarly, another family expressed their motivation for PGD is based on the desire to 
have a large family, however the male partner find his desire to be greater than that of 
his partner. However, the PGD process was later interrupted by a naturally conceived 
pregnancy. 
“It is natural to want to have many children, this is similar to one’s desire 
for wealth” (Fm5-M, lost affected children and PGD cycle is interrupted by natural 
conceiving).   
It was previously highlighted that the desire for a biologically related healthy child, 
loss of at least one affected child, multiple miscarriages or experiencing years of 
complex medical and obstetric histories were the main reasons for considering PGD 
(Karatas et al., 2010b; Kalfoglou, Scott & Hudson, 2005; Lavery et al., 2002; Roberts 
& Franklin, 2004; Farra et al., 2008; Alsulaiman & Hewison, 2006). These factors also 
seemed to play a role in motivating families in this study as all of them had experienced 
at least one affected child or multiple losses at the same time it had delayed some 
families from parenting another child; thus delayed their PGD plan. 
Some participant mentioned that despite the strong wish for a healthy child, it took 
them a while to consider parenting another child. They felt that they had a 
responsibility to their affected child(ren) as a result of the intensive care and medical 
attention required. The following participant describes the amount of suffering they 
experienced with their affected children, and how this made them defer having more 
children for couple of years:  
“The disease my children suffers is really horrible; the child is distressed and 
irritated all the time. Spasticity made the care very difficult, difficulties in feeding, 
washing, sleeping and even to get them calm. The required care keeps us occupied. 
We had to suspended our pregnancy plan for eight years, which deprived our desire 
to have many children” (Fm1-M, no healthy, many affected children, experienced a 
PGD cycle). 
Procreation and establishment of a family is a fundamental purpose of marriage in 
Islam. The Quran itself describes both riches and children as “allurements of the life 
of this world” (18.46; 63.9; 64.15) and, at the same time, progeny is considered a 
blessing and a reward. However, when Islamic Shari’a suggested procreating, they 
emphasised the importance of the role of parents as the providers of adequate 
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nourishment, protection and wealth for their children so that they could be of benefit 
to the family and society. As a result, children would be raised as virtuous, civil and 
healthy, and therefore responsible in society (Atighetchil, 2007). On the other hand, 
Islam discourages raising children in situations in which they may become a source of 
harm to the society (Atighetchil, 2007). In The Holy Quran, Allah said: ‘Do 
Beneficence, Allah likes Beneficent people’ and the Messenger of Allah said: “The 
most gruelling trial is to have plenty of children with no adequate means.” This was 
also a motive to have healthy rather than many sick children which is non-beneficent 
to the family and the society.  
Many Muslims believe the interpretation relates to having many children. Others refer 
to physical strength and health as being important in order to worship and be of benefit 
to the nation (Serour & Dickens, 2001). Utilising a procedure such as PGD was 
therefore particularly important to the participants, as it would ensure health in future 
offspring by being able to select against disease. 
The desire for a healthy child was reported to be equally motivating for most partners. 
However, three shared a different view point - these cases had reported disagreements 
due to logistical issues such as financial burden and partner concern about the side 
effects of the treatment on his wife, as the following partners reported:   
 “At some stages, I felt my partner is not motivated for a new cycle and takes 
me time to get the other party engaged but cannot say not supportive, he mostly 
thinks of the financial burden as well the side effects of the treatment on me” (Fm6 
F; several cycles with no healthy embryos).  
Overall, participants were equally motivated for PGD. There was no gender 
dominance although carrier partners (n=2) felt more motivated. In contrast to this 
finding Van Rij et al (2011) reported that females dominated the decision-making 
process in a cohort of Dutch PGD users (van Rij et al., 2011). Since the majority of 
couples in this study are carriers for autosomal recessive conditions, they may feel that 
they share the burden of being a cause of the defect in their progeny. In contrast in the 
Dutch group, 56% are carrier females while the AR carriers make up only 18% of the 
group. However the group in this study is small and the findings from the study may 
not be representative of the population.    
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4.3.1.2.   Can’t have another affected 
The experience of having an affected child was described as emotionally and 
physically draining and avoidance of similar suffering in the future (for both the 
parents and future children) was highlighted as a significant motivating factor (Farra 
et al., 2008; Lavery et al., 2002). A similar finding was identified in this study where 
most families had taken care of a chronically ill child who was frequently hospitalised 
and for whom there was no cure. For the genetic conditions included in this study 
individuals had a shortened lifespan, often associated with pain and suffering in the 
final stages of the disease.  Family 4, who has affected children described the trauma 
of the child never achieving any developmental milestones due to the disease.  
  “When I see other children play and talk, I feel sorrow for my children who 
never had such an opportunity and for me who never had the pleasure of the 
experience “(Fm4- F, had affected children, no healthy). 
The couple in family 8 who lost a pregnancy presenting with multiple anomalies and 
had no living children found their experience was difficult and felt they could not go 
through it again:  
“It was a difficult experience; my first pregnancy took all the joy away. Every 
visit was to watch for death, more warning signs. No single sign of joy. It was 
horrible, I can’t go through it again” (Fm8-F, lost a child with congenital anomalies).  
This feeling was also reported by family 3 who had an affected child but had not 
experienced loss.  
“My first child was affected, we struggled for the diagnosis and on his care. 
We were afraid to have another child that can be similarly affected and live the same 
experience” (Fm3-M, have an affected child, but never experienced PGD as it was 
interrupted by an unplanned natural conception). 
These participants felt overwhelmed by the thought of having another affected child 
and thought that it would be sensible to prevent suffering in a future child.  
In addition, all families reported that having an affected child had changed their family 
and social dynamics. It was typical for the mother of an affected child to become more 
isolated and less involved in social activities and for the father to have frequent 
absences from work or be less productive in the work environment. One participant 
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expressed that his low productivity at work had become noticeable to his work 
colleagues after having several affected children.  
“I am not focused at work. My mind is scattered and my work colleagues noticed 
that I became less productive than before. My mind is always occupied by my sick 
children” (Fm4-M, had affected children, no healthy). 
4.3.1.3.   Avoidance of TOP  
Another motivating factor common to all participants was the avoidance of termination 
of an affected pregnancy. Three families (37.5%) had considered prenatal diagnosis in 
a previous pregnancy but had found travel abroad for a TOP overwhelming. Two 
families received a result indicating an affected fetus and terminated a pregnancy 
overseas. For both of these families the experience was distressing both due to the 
nature of the procedure and being unfamiliar with the foreign country’s healthcare 
service. 
Here one of the couples described their experience with a TOP done abroad plus their 
experience of the loss. The feel they would not consider this option again: 
“It was difficult, very difficult experience. I can’t explain how much we struggled 
with the emotions of going through termination. I would not consider it again” 
(Fm4-F, had affected children, went through TOP). 
This experience was similarly described as difficult by family 7 who lost multiple 
affected children in their first year of life and went through TOP following the news 
that another pregnancy was affected after undertaking PND.  
“It was difficult, too difficult to see your child die in your lap and there is 
nothing that you can do. We tried termination, and I am telling you it was the hardest 
experience we went through” (Fm7-M, lost affected children, has no healthy children, 
went through TOP). 
Five families (62.5%) were from an Islamic sect that did not consider TOP an option. 
For these individuals PGD was the only option available to avoid affected children.  
“I am willing to go through 20 cycles rather than go through termination 
which I cannot accept morally or religiously” (Fm2- M, has affected children, went 
through a PGD resulting in no pregnancy). This family finds that TOP conflicts with 
their religious background and moral perceptions.  
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Views concerning TOP are strongly influenced by the perception of the period of 
ensoulment. TOP is permissible in certain Islamic sects prior to the period of ‘the 
breath of life’ however the interpretation of this ranges from 40 to 120 days. The 
majority of participants (57 %; 8/14) reported that their consideration of TOP was 
complicated by the uncertainty of the time period in which ensoulment could take 
place. Serour (2008), in the symposium of religion in assisted reproduction, stated that 
“Most Muslims adhere to the view that human life requiring protection commences 
two weeks from conception and uterine implantation” (Serour, 2008). The authors 
believe that few Muslims are aware that fatwas (Islamic permission) do exist that 
enable them to consider TOP until 120 days. All participants in this study were 
however aware of the permissible Fatwa. It is not unexpected that the study group was 
more informed than the general population given the fact that they had received 
extensive genetic counselling and maybe because they were educated and did thorough 
research.  
In contrast to TOP, the religious guidelines concerning PGD in Islam are clearer as the 
majority of Muslim jurists approve PGD and IVF as not against the will of God and 
not modifying creation (Atighetchil, 2007). A consensus of several Islamic 
conferences encouraged PGD, where feasible, as an option for couples at exceptionally 
high risk to avoid clinical pregnancy termination (Serour & Dickens, 2001). 
Participants had further researched information about ethical and religious aspects of 
PGD to aid their decision-making process. Three participants (21.4%) additionally 
contacted a religious scholar to obtain further insight into the religious acceptance of 
the procedure. However, another three (21.4%) reported that it was enough for them 
to receive the information from the genetic team.  
Of interest is the fact that partners in some couples had different perspectives on the 
guidance from a religious leader. An example of this can be seen in the case below 
where, although the wife had contacted a religious leader for guidance of proceeding 
with PGD, her husband had based his decision on his own interpretation of Shari’a.  
 “I believe every person should assess their family dynamics and 
consequences without crossing the red lines such as termination of pregnancy. I 
know that sometimes religious leaders are diplomatic and cannot give an open fatwa 
as a precaution of misusing the permissions. That is why reading about the basics 
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of Shari’a (Islamic Law) helped me to make my own decisions that suited my 
circumstances” (Fm6-M, lost affected children, went through several PGD cycles).  
 
4.3.2. Theme 2  
 
4.3.2. Anxiety “Taraqub: Arabic metaphor” 
 
4.3.2.1.   Road to PGD  
PGD became an option to all participants once a genetic diagnosis was obtained. Many 
families (43%; 6/14) underwent a long journey to reach a diagnosis due to a lack of 
genetic facilities and resources in the country. The recent establishment of a genetic 
clinic in 2012 has enabled easier access to genetic testing in Oman (Rajab, Al Rashdi 
& Al Salmi, 2013; Al-Thihli et al., 2014). Following the diagnosis of a genetic 
disorder, families are counselled about the available reproductive options including 
PND and PGD. However, due to the restrictions on termination in Oman, PGD is often 
preferred and requested more frequently compared to PND to avoid moral and 
religious dilemmas (Bruwer et al., 2014). This was found in this group and discussed 
in the previous theme. Currently both options require travelling abroad and are 
associated with emotional and physical stressors. However, PND is associated with a 
lower financial burden on the family. Nonetheless, families who have experienced 
PND find it difficult to consider in future pregnancies (as discussed in theme 1). 
 All families learnt about their risk after having an affected child or pregnancy. The 
journey to diagnosis varied from four months to twelve years among families. As 
previously discussed, the availability of genetic diagnosis in recent years, and 
accessibility to expertise, enabled affected families to obtain a diagnosis more quickly 
than before. Furthermore, the availability of new testing techniques such as next 
generation sequencing (NGS) and whole exome sequencing (WES) increased the rate 
of diagnosis further. Being aware of the genetic diagnosis, and hence the recurrence 
risk, led families to consider alternative reproductive plans such as PGD. An example 
of this is illustrated in the following quotation: 
“We lost many children with the same disease and it took us more than 10 
years to know what was going on. The first time we met the geneticist in this clinic 
three years back was the first time we heard about a potential diagnosis. She 
mentioned PGD and we felt this would be our hope to have a healthy child. It took 
57 
 
us two years to get an answer from the geneticist and after that we immediately 
started the arrangements for PGD” (Fm2, lost affected children, unsuccessful PGD 
cycle).  
Similarly, a participant who waited for five years to obtain a diagnosis for his affected 
children explained that the diagnosis helped them to consider an alternative 
reproductive option: 
 “I had many affected, no diagnosis was available for more than five years. 
Once I got the diagnosis in 2013 and counselled about the option; I felt this is my 
best to consideration” (Fm4-M, had affected children, unsuccessful PGD cycle).    
PGD is expensive and many couples found it overwhelming to consider such an 
expenditure. Six participants (43%) stated that the availability of the financial support 
from the government was a facilitator for considering PGD. Till early 2015, couples 
at risk with no healthy children were eligible for financial coverage of one PGD cycle. 
Couples who had been sponsored and experienced a failure, would have to consider 
self-payment for future cycles. However, due to budget constraints since mid-2015, 
caused by the decrease in oil prices, funding has been suspended.   
 “I would not be able to make it without receiving the fund. However, for the 
next trial I will need more time to make my own budget. You know it is an expensive 
procedure” (F4M/F, no healthy embryos). 
Drazba et al (2014) reported that “cost is salient” in decision making for PGD (Drazba, 
Kelley & Hershberger, 2014). The couples in Drazba’s study who lived in states with 
IVF financial coverage did not report cost as a concern while those who were not 
supported commented that cost delayed their decision-making process (Drazba, Kelley 
& Hershberger, 2014). Although financial funding was a facilitator in the current 
study, families who received governmental support had to go through a time-
consuming administrative process. This meant waiting for the funds to be released 
before they could start the procedure. The average waiting time to start the IVF-PGD 
arrangements, among the participants who accessed governmental support, was one 
year. Four families took less than one year (four to six months) to start the actual 
procedure. Three of them were self-funded and one, despite receiving financial support 
and therefore being delayed by the lengthy administrative procedure, accessed PGD 
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earlier as no pre-PGD optimisation was required (they had a chromosomal 
rearrangement). 
All participants suggested that the government should consider bringing the 
technology into the country to facilitate accessibility. The health care system should 
be made aware of the fact that the amount paid for PGD would be incomparably lower 
than the amount required for providing care to a chronically sick child with a genetic 
disorder necessitating intensive medical treatment and investigations. All Omani 
citizens are provided with full free health care for all medical appointments, 
treatments, interventions and hospitalisations. Therefore, participants in this study 
were surprised by the restriction of funding for PGD since they felt that PGD was a 
cost effective strategy. Couples emphasised that if PGD was subsidised it would 
significantly reduce hospital expenditure and the burden on the medical care system. 
This is clearly described by Fm2-M who was not granted funding for PGD because 
they did not meet the criteria even though they had lost many children with a 
neurodegenerative disease: 
“Having the support of the government would mean that less money would 
be spent treating an affected child. Look how much they paid to take care of my 
affected children while if I have the support for PGD they could avoid such an 
expense” (Fm2-M, lost affected children). 
Tur-Kapa, 2010 suggested that providing PGD for American CF carrier partners would 
save 2.3 millions of dollars spent on providing care per affected individual for an 
average life of 37 years (Tur-Kaspa et al., 2010). Similar comments were made by the 
participants for a cost effective strategy plan. All participants recommended that the 
government should be more directly involved in establishing regulations concerning 
procedures required in the PGD and IVF process. Three participants (21.4 %) felt that 
they had undergone unnecessary investigations and that the centre may have had a 
more commercial (financial) rather than patient-based interest. Similarly, American 
PGD users in Kalfoglou’s study wanted regulations and guidelines but did not want 
them to be imposed by the government. The users argued that the government could 
make it too restrictive, reducing the chance of accessing PGD (Kalfoglou, Scott & 
Hudson, 2005).  
59 
 
Twelve participants (85.7%) recommended bringing the technology to Oman and 
establishing the service within the country. They considered travelling abroad an 
obstacle, even though this was only to a neighbouring country. For one family, the 
choice of centre was largely dependent on location so that they could travel back home 
and look after their affected children during the treatment period. Another family 
stated that they had to consider the proximity of a centre to reduce the time required to 
be abroad due to their work obligations.  
In addition to the treatment itself, families had to consider the issues of travelling 
abroad such as choice of centre and accommodation. Some families selected a PGD 
centre due to proximity to Oman, either to reduce financial costs associated with 
travelling or because they needed to return to Oman to care for affected children: 
“We had to come in between to check on my children. It was not a good 
decision, but I couldn’t leave my children for three weeks” (Fm4 M/F, had living 
affected children). The parents were the primary carers and unable to leave their 
children in the care of others who were inexperienced with the disease management. 
Another family reported that travelling abroad was physically draining: 
 “We had to select a place that was close to the centre which was not easy as 
it was more expensive. As a result, we had to walk for more than 20 minutes every 
day including the day of the last injection and due to the hospital appointment it 
meant it was after midnight. We did not feel safe“ (Fm1 M, successful PGD cycle). 
This has also been highlighted in western populations where PGD was found to 
consume energy, time, attention and money (Roberts & Franklin 2004). These families 
were confronted with many stressful factors that they had to consider when undergoing 
PGD. All these add further stress to the already stressful treatment.  
4.3.2.2.   Waiting for exam results 
Anxiety was a persistent feeling during the treatment and found to be highest prior to 
and after implantation. High levels of anxiety were also reported during the wait for 
the test result of the embryos. Participants described waiting to hear if they had healthy 
embryos as “waiting for a final exam result”.  
Similarly, another participant described the stressful time waiting for embryos test 
results as a hard time where the time moves slowly.   
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“You feel the time does not move, hardly move in these five days” (Fm8-M, several 
unsuccessful cycles). 
Similar feelings were expressed by a participant who went through several cycles 
before having a successful pregnancy.  
 “It was the most difficult time, you went through all the effort, tolerated and 
managed the stress of the treatment and the travel, paid all the money and then 
waited for the outcome of this effort without having any input. As if you had a 
difficult exam and had to wait for five days counting the time waiting for the results” 
(Fm7-M, several cycles, successful pregnancy). 
It had been reported that the anxiety prior to and after implantation of embryos  
(Järvholm, Broberg & Thurin-Kjellberg, 2014; Karatas et al., 2010b; Karatas et al., 
2010a). Many families find themselves confronted by the unavailability of embryos to 
be transferred (Karatas et al., 2010b) which was acute distresses and disappointment. 
This research did not focus of the level of anxiety and this area remains unexplored in 
our patients. Nevertheless, it would valuable for the future study to explore the levels 
of anxiety before and after embryo implantation in a larger sample.  
Families who had healthy embryos described the waiting period before the pregnancy 
test as another stressful event. Some families who had a negative pregnancy test 
explained that despite the negative result, knowing the answer reduced the anxiety and 
afforded relief as mentioned by the couple in family 2: 
“You know, it is very stressful, but once you have the results you get less 
stress, no matter what is the result, just to know the result is a relief” (Fm2M/F, went 
through unsuccessful cycle).  
In contrast to family 2's experience, the couple in family 7 felt distressed after a 
negative test and not relieved. Here they describe one of the failed trials: 
“When we received the test results, which was negative we didn’t know what 
to do or what to say. We were confused, kept silent and went home. After that my 
wife was distressed for many days” (Fm7-M, went through several cycles, had one 
successful.  
But they found the whole experience emotionally and physically stressful as did others 
who reported a distressing experience: 
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 “It was stressful time, not an easy step” (Fm4-M, unsuccessful PGD cycle). 
Similarly, another participant who went through several unsuccessful cycles also 
reported that the experience was stressful. She was emotional while expressing her 
feelings as she recalled stressful memories. The researcher offered to stop the 
interview, but she expressed her willingness to continue: 
“I can’t say it was easy, it was too difficult and stressful (was emotional) I 
am sorry but it brought stressful memories” (Fm8-F, more than one cycle, no healthy 
embryos).  
The couple who did not report a stressful procedure believed that their experience was 
in line with their expectations. They had a successful pregnancy which could have 
normalised their emotions or could have been due to good preparation as they reported. 
As mentioned in chapter 3, the female partner did not attend the interview, and she 
could have a different perception as it is usually the female who experiences the 
invasive and stressful treatment in PGD. However, the male partner explained that they 
read a lot and met with other families who had experienced IVF. Two participants who 
were cautious of the procedure delayed the start of the treatment as a result of their 
uncertainty and both of these couples became pregnant spontaneously and were unable 
to initiate a treatment cycle.  
Despite the stress, PGD remains a better option for the majority. Eleven families would 
consider using PGD for future pregnancies (78.6 %) and expressed a strong desire to 
do so. For the three (21.4 %) that would not consider PGD for future pregnancies, the 
outcome of the procedure (being unable to achieve a healthy pregnancy) and financial 
burden were reported as the main reasons. Two couples had no healthy embryos 
following several PGD cycles. Both were reluctant to consider another PGD cycle due 
to emotional and financial concerns. Nevertheless, they reported that they did find 
PGD to be an easier option than TOP which was restricted in Oman and by their 
interpretation of the Islamic sect of their belief (Bruwer et al., 2014). One family who 
experienced TOP following a PND of an affected fetus still believe PGD is better but 
might consider PND again due to financial concerns.  Similar figures were reported in 
Lavery’s study where 77% of the couples who undertook PGD would consider PGD 
again while only 15% would opt for PND (Lavery et al., 2002). In this study 78% of 
couples find PGD a better option for their next pregnancy.  
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However, this participant felt it would be emotionally overwhelming to go through 
another cycle after experiencing several unsuccessful cycles: 
“I went through many cycles; none had worked. It was difficult, very stressful 
and exhausting. I’m hesitant to have another one shortly”. (Fm8-F, despite finding 
PGD stressful still believe it was easier than termination).  
4.3.2.3.   She was not herself 
Four females reported that they had experienced mood swings and emotional 
fluctuation during the treatment. Some examples follow: 
“I read a lot, I thought I‘m ready but I realised that there was more than that. It was 
painful and stressful” (Fm4-F, PGD cycle no healthy embryos). 
Another participant experienced mood swings, pressure and stress during the treatment 
to the extent that she wanted to discontinue the treatment:  
 “I had severe mood swings, I felt strong pressure and exhausted. I was 
about to stop the treatment” (Fm8-F, many PGD cycles no healthy embryos).  
Interestingly, their partners reported that they observed this but that it had taken them 
time to connect it to the treatment.  
“She was not her usual self. She was totally different; mostly angry, anxious 
and tired. She spent most of the day sleeping and depressed. First few days, I thought 
she is psychologically sick, then I realised it is a side effect of the hormonal 
injection” (Fm4-M, unsuccessful PGD cycle). 
Another male partner who observed changes in his wife was surprised at the beginning 
until he noticed these changes elevated after every hormonal injection. He then 
appreciated the stress his wife went through, became more tolerant and started to 
provide more support.  
“She was different, anxious, stressed and nervous. If you don’t appreciate 
what they are going through, you will lose it. I just had to be calm so she can be 
calm” (Fm8-M, many unsuccessful PGD cycles). 
The PGD journey has often been reported as "emotionally draining" (Cunningham, 
Goldsmith & Skirton, 2015). Lavery et al (2002) identified that 41% of their 
participants found the treatment cycle to be extremely stressful (Lavery et al., 2002). 
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It is not unusual for couples to be emotionally affected during the PGD journey (Katz 
et al., 2002; Drazba, Kelley & Hershberger, 2014; Karatas et al., 2011; Karatas et al., 
2010a). Similarly, couples in this study experienced the emotional burden of stressful 
treatment cycles.  
Half of the families reported a painful experience as a result of side-effects or 
complications of the procedure. This participant who developed some side effects, did 
not require hospitalisation: 
  “I had strong pain on my lower abdomen which increased with time. I 
reached the stage where I was not able to walk” (Fm8-F, several unsuccessful cycles). 
While this participant developed chronic health problems after many PGD cycles, she 
expressed her desire for continuation of trials while her husband was concerned about 
her health status (as mentioned earlier).  
 “I had different side effects, I developed a chronic vascular problem, my 
husband is always worried about my health and potential side effects “ (Fm6-F, 
unsuccessful cycles). 
Male partners also find it difficult to watch their wives going through such invasive 
treatment. This participant expressed his emotions about seeing his wife being given 
daily injections and undergoing thorough investigations:  
 “it was hard for me to see her injected several times; daily injection for 
sixteen days: that was hard for me” (Fm-1-M, successful PGD cycle). 
4.3.3. Theme 3 
4.3.3. Unforeseen   
Couples undergoing PGD treatment experienced unexpected issues that they felt 
conflicted with their religious and cultural beliefs. Such issues had not been addressed 
in the booklets, websites and forums they researched and were concerning for them.   
4.3.3.1.   Loss of intimacy and autonomy  
Most participants (62.5%) realised that the procedure involved different teams which 
meant that their medical information had to be disclosed. Female participants felt 
uncomfortable being treated by a male doctor and expressed their preference to be seen 
by a female doctor. Male participants also reported that they felt uncomfortable with 
their wives been seen by male doctors although they accepted this as there were no 
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alternative options. The main practice and preference in Oman, based on Shari’a, is 
that female patients are examined by female gynaecologists and obstetricians. As a 
result, being examined by a male was not a comfortable experience.  
 “...when they told, you have only one healthy embryo, my mind was occupied 
what if pregnancy does not happen and then my wife has to repeat the treatment and 
seen again by male doctors. It was harsh for me, but you know (sadly /.. / with slurred 
voice) I can’t see another solution” (Fm1-M, successful cycle).  
Gender preference of care providers by PGD users may be unique to this study as a 
result of the conservative religious and cultural backgrounds of the population group. 
Nonetheless, the topic remains unexplored in the literature.  
Two families expressed the desire to be involved in the embryo selection decision. 
One of them wanted to select a non-carrier embryo with a gender different to their 
affected children as a ‘fresh start’. They understood the disease was not linked to 
gender but felt that having a healthy child of the opposite sex would erase the painful 
image of the previous affected children. A couple may request the opposite gender to 
their affected child if, for example, it had an X-linked condition where they would 
consider avoiding a brother to protect the affected child from seeing a younger brother 
achieving what he would not do (Lashwood & Say, 2014). According to ESHRE 
guidelines PGD should not be used as a method to provide sex selection for non- health 
indications (De Rycke et al., 2015; Thornhill et al., 2005). This finding and that of 
Katz et al (2002) highlight the participant’s interest in being involved in the selection 
process of embryos (Katz et al., 2002).  The concern around implanting a healthy 
carrier has been raised in previous literature (Katz et al., 2002) and was raised by one 
participant who felt disappointed to know that a carrier embryo had been implanted.  
Participants were also interested in being more involved in decisions related to their 
treatment process:  
 “I wish I could have been given the chance to understand the treatment 
procedure. I felt that I had to follow their recommendations and go through steps 
whereas I read later that could have been altered based on my conveniences; like 
timings of the injections” (Fm2-, unsuccessful cycle). 
This was not unique to this participant as Kalfoglou, Scott & Hudson (2005) had 
reported that their patients would limit questions to avoid being perceived as a difficult 
65 
 
patient (Kalfoglou, Scott & Hudson, 2005). The feeling of losing the control and 
autonomy to decide on the treatment was an unexpected issue and was inconvenient.  
Likewise, men reported feeling shocked when informed that they would have to 
provide a semen sample. Those participants also mentioned that the request 
underscored the reality of the procedure - very artificial as compared to the natural 
conception process.  
 “I was shocked when asked to provide a semen sample. It was not easy and 
made me feel insecure. I realised at that moment this is a very un-natural procedure, 
you cannot compare it to the natural procedure with warm feelings” (Fm1-M, a 
successful cycles). 
Masturbation is against Shari’a law as it could lead to an illegal sexual desire. When 
sexual intercourse takes place within the marriage it maintains the legal sexual desire 
(Inhorn, 2007). This reflection was reported by Muslim males in Lebanon and Egypt, 
where they experienced anxiety associated with semen collection through 
masturbation for IVF. Their anxiety was compounded by the guilt associated with 
masturbation (Inhorn, 2007). Similar concerns were highlighted among the males in 
this study. Such a concern might be unique to certain religious groups such as Muslims 
and Orthodox Jews, due to their religious restrictions (Inhorn, 2007).  
4.3.3.2.   A piece of mine 
Families who completed cycles of treatment and had fertilised zygotes felt some 
degree of attachment to the embryos. These participants reported that they felt 
emotionally and mentally attached to their embryos. Fm1-M described it as follows:  
“I followed them to the lab, wanted to see my embryos. I was not allowed. I 
wish they could show us the embryos and involve us in the selection procedure” 
Another participant who went through one cycle with no healthy embryos felt attached 
to the embryos and was described them as viable babies: “they are my babies in an 
incubator” (Fm4-M, had unsuccessful cycle). A similar finding was described were 
women call their embryos as live children (Karatas et al., 2010b).  
Attachment was so strong that some participants reported that they wanted to implant 
an affected embryo when no healthy embryos were available:  
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   “They did test for everything (PGS) plus the mutation we have and we got 
one free of the mutation but the other test showed something wrong. My wife wanted 
to implant that one but I had to convince her that we came to avoid having a sick 
child.” (Family 4, unsuccessful cycle).  
One couple, in separate interviews, expressed that they would struggle with the 
concept of discarding the embryos if they had been given a choice. They described the 
affected embryos as: 
 “a piece of mine had been discarded”.  (Fm8-M, unsuccessful cycles). 
This sentiment was echoed by another participant (Fm6-M) who went through several 
cycles and experienced difficulties every unsuccessful cycle: 
 “Went through several cycles and no healthy embryos, we came to select healthy 
however knowing that those, the affected, will be discarded, felt as throwing a piece 
of mine”. (Fm6-M, unsuccessful cycles). 
Similar findings were reported among 62% of Saudi couples who felt attached to 
embryos, however did not mind discarding embryos (Alsulaiman et al., 2010). This 
could be explained by the main reason to undergo such an invasive procedure being to 
avoid having an affected child. Most families would not consider implanting a child 
identified with a potential disability. Such an attitude was evident in some couples in 
this study.  
In contrast, some participants were confused as to how to deal with the extra healthy 
embryos. It was a dilemma for those travelling to Jordan, where the option was 
available. This was experienced by family7 who was hesitant to freeze excess healthy 
embryos. Although these individuals were initially against freezing, they were later 
convinced by the medical team to freeze their healthy embryos. As it turned out, the 
decision to freeze embryos was particularly important for this couple as the first 
implantation failed.: 
“I was against freezing embryos. I was worried about potential mistakes of 
mixing embryos as we had one healthy and I was afraid to keep it. Drs assured me 
about their storing procedure. Thanks God, I was encouraged by them and other 
families who had experience. That really helped!” (Fm7 had successful pregnancy 
after implanting a cryopreserved embryo from a previous cycle). 
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However, this is not an option for couples undergoing PGD in the UAE, where freezing 
embryos is restricted by Law (Inhorn, 2016). A couple who underwent PGD in UAE 
followed by unsuccessful implantation had to change their clinic to a country such as 
Jordan where they can cryopreserve their embryos.  
“ we had been in a country that restricted freezing (UAE) and we had no 
pregnancy. We thought as they implanted many embryos we will have at least one 
that may stick there, but it didn’t. The next plan is to Jordan where we can freeze if 
we had excess healthy” (Fm1F/M, unsuccessful cycle). 
Moreover, couple who had implanted embryos felt attached to the healthy embryos 
when implanted and took extra precautions. These included the avoidance of sexual 
activity, hard work, heavy lifting and some foods that are culturally believed to cause 
miscarriage as shared by this participant: 
“I was taking extra care after returning my eggs, I was even avoiding some 
food my friend was restricted to eat when she was pregnant to avoid miscarriage” 
(Fm2-F, had implantation, no pregnancy). 
Participants expressed attachment to the healthy implanted and frozen embryos but did 
not object to discarding the affected embryos as they believed the purpose was to avoid 
an affected pregnancy:  
“I feel attached to implanted embryos and I take precautions when 
implanted, however, I have no objection to discard the affected as the affected 
embryos are meant to be avoided” (Fm6- F, went through several unsuccessful PGD 
cycles).  
Attachment to transferred embryos in PGD was less than that with IVF (Karatas et al., 
2010a). This can be corresponding to the motive behind the IVF/PGD; as achieving 
pregnancy in the IVF and looking for a healthy child in the PGD (Karatas et al., 2010b).  
Overall participants felt attached to their embryos at different levels; prior and after 
implantation. Some had been attached even to the affected embryos. However, to the 
researcher's knowledge, no study has examined the attachment of PGD couples to their 
healthy versus affected embryos. This could be another area for research and study.   
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4.3.3.3.   Cannot remember a failure rate  
Most participants understand that PGD is a means of achieving a healthy baby. The 
majority were not concerned about the technical aspects or success rate before starting 
the procedure and were focused on achieving their main target: having a healthy child. 
It is common for couples undergoing PGD to believe that it is a promise of having a 
healthy child and not just a method of avoiding a disease (Karatas et al., 2010b; 
Järvholm, Broberg & Thurin-Kjellberg, 2014). Despite being counselled about the 
success rate the couple can figure the reality when they experiencing failure of a PGD 
cycle. Some examples of this are seen below: 
 “I never expected a failure. It was too harsh to hear it. I don’t think I heard 
the potential of failure before, maybe I didn’t want to. Please advise people in my 
position not to be optimistic” (Fm4-M, lost affected children, went through PGD cycle 
resulted in no healthy embryos).  
Achieving an unsuccessful pregnancy after implantation was also reported as an 
unexpected event. This can be correlated to the prior expectation of a high success rate 
as previously discussed.  
 “when we had the genetic results, we were very enthusiastic and rushed in the 
arrangements for a PGD cycle. I was too optimistic that by the end of the treatment, 
I will have a healthy baby. I can’t remember anything about the failure risk” (Fm2F, 
lost affected children, went through PGD cycle with no successful pregnancy). 
Another participant who believed the success rate was 80%, but he was shocked with 
the failure and figured it can be only 20%:  
“I heard the information of low success rate; however, in my mind this was up to 
80% or more. May be I was very enthusiastic and pushing to undergo the treatment” 
(Fm2-M, lost affected child, went through PGD cycles with no pregnancy). 
 “I never expected to not have a healthy embryo. All my thoughts were how 
to prepare for the coming baby and what the name would be”. (Fm4-F, had affected 
children, PGD cycle no healthy embryos).  
Although this participant acknowledged that the failure rate had been discussed in 
several counselling sessions, the hope for success and a healthy pregnancy remained.  
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The higher expectation of success rate, despite extensive counselling, has been 
reported by other PGD users (Kalfoglou, Scott & Hudson, 2005; Karatas et al., 2010b). 
Furthermore, couples may believe that failure rates may be lower for them as they do 
not present with infertility concerns. However, many publications report a lower 
pregnancy rate within the PGD group as compared to the IVF group due to the 
exclusion test to avoid the genetic risk (Kuliev & Rechitsky, 2015; Lashwood, 2014; 
Moayeri et al., 2016). This research finding finds similar attitudes of couples towards 
the expected success rate. Couples could be strongly driven by the end outcome hoping 
for a successful pregnancy.  
“I used to believe it is 90% successful, after many trials, I came to believe it 
is less than 50%. But I am still motivated even with lower chance” (Fm8-M, went 
through many unsuccessful trials). 
4.3.4. Theme 4 
4.3.4. Secrecy  
4.3.4.1.   PGD child “Haram” (sinful) 
Cultural acceptance was found to vary based on the perception of other family 
members. For example, if a family member had experienced infertility and therefore 
utilised IVF, PGD was acceptable within the family or surrounding society. In this 
situation, the couple would openly share their intention for using PGD to resolve their 
genetic problem. However, if the couple were the first to undergo such a treatment 
within their surrounding society or social network, they were more reluctant to share 
their intention of undertaking PGD. Initially they faced the difficulty to ask their 
parents for DNA samples; as a requirement for pre-PGD optimization. Some explained 
that this is requirement to establish a genetic diagnosis. As stated: 
 “ we didn’t want our parents to know. We told them we want to know what is 
the genetic problem; which is the truth for our future children” (Fm3 F/M, 
interrupted). 
For those couples (62.5%; 5/8) who had not informed any family or did not openly 
discuss the use of PGD, the main reason for non-disclosure was for the benefit of the 
child so as to protect him/her from possible stigmatisation in the future (by the family 
members or society in general).  
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For instance; this participant expressed that he would not share the uptake of this 
treatment with any of his circle as he believes people can be judgmental since they 
don’t know about their major problem and what the alternative would be: 
“I’m quite sure that this is the best option for me. However, I will not disclose 
it with any, even my parents, you know, I mean people can be judgmental and 
stigmatise the child in the future. So if I keep it secret, it is for the child’s 
protection” (Fm6-M, lost affected children, unsuccessful PGD).  
Similarly, another participant feels that she wouldn’t mind disclosing the information 
if society is well aware that this is a treatment and is allowed, not forbidden, in Islam. 
She herself had heard people describe the child born through IVF as a “Haram” baby. 
Therefore she would keep it secret as she wanted to avoid the child being stigmatised. 
   “I am happy to educate people about PGD, to advocate for this treatment as 
any other treatment, but at this stage I cannot risk my PGD child to be stigmatised 
in ignorant society /.../I wish I can go out in public or out in the media and talk to 
people telling them that PGD is a treatment, not a luxury selection. I wish I can 
correct their perceptions that this is something correct under Islamic permission and 
not Haram (Haram: forbidden in Islam which can be sinful) to do it” (Fm3-F, PGD 
interrupted). 
Another family believed that there was no advantage to disclosing the fact that they 
had gone for PGD. They are comfortable sharing with relevant people like health care 
providers or religious scholars, but it would be unnecessary to share with other people. 
As stated: 
“You are a health care provider and he is a religious leader, other than that no 
point to share even with my siblings and my friends” (Fm7-M, had a successful 
pregnancy after different trials). 
Family 5 also shared similar concerns were they believe that the PGD child could be 
stigmatised as a designer baby. 
“ I know people who labels that child as the designer baby or tube baby or 
Haram baby, many labels. I am not happy to inform. This is very private issue where 
me and my wife decided not to disclose with anyone” (Fm5, interrupted). 
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Although the majority of participants expressed their concern about society’s 
perceptions, disclosure to parents and close siblings did occur. This was reported by a 
participant who did thorough reading and understood the risk of the treatment to his 
wife. Therefore, he had to inform her parents and ask for a permission: 
“I informed my wife’s parents. It is a responsibility that I am taking her for a 
treatment; which has many side effects and complications; what if something wrong 
had happened! I wanted their approval and they didn’t resist. I urged them not to 
share the information to anyone”. (Fm1-M, successful pregnancy through PGD).  
The reported perception contrasts that of the Saudi couples in which 100% of the 
studied group stated that their extended family and friends were informed and 
supportive of PGD/IVF (Alsulaiman et al., 2010). This could be because the PGD 
service is established in Saudi whereas in Oman it is relatively unknown. This could 
have played a role in cultural awareness and acceptance.  
4.3.5. Theme 5 
4.3.5. Me and my partner  
All participants except two reported that their journey through IVF-PGD had 
strengthened their relationship. They believed that the struggle provided them with a 
greater appreciation of their partner. In a third of the participants in Lavery’s study the 
treatment had a negative impact on their relationship, while for the other third it 
brought them closer together (Lavery et al., 2002).  
“though I was stressed, but I tried to hide my worries to make my wife calm. 
It wouldn’t work if both of us were nervous, someone should be calmer and support 
the other”. (Fm8-M, many unsuccessful cycles). 
Participant (Fm8-M) felt the experience had brought him closer to his wife and 
strengthened his faith in God. He expressed that his faith had strengthened and also 
helped him to tolerate the stress and understand his wife’s stress during the treatment 
(mentioned earlier). His wife reported independently that his faith was a big help and 
support for her during their unsuccessful experiences (Fm8-F).  
“His faith was a power for me. He was always positive and able to keep me 
calm and renew my hope” (Fm8-F, went through several unsuccessful cycle).  
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However, one partner reported PGD to be a burden on their relationship as the carrier 
partner was preoccupied with having a healthy child. In his opinion, this led her to 
ignore the potential side effects and harm that could occur from repeated cycles. This 
partner also believed that the financial burden had acted as an additional stressor on 
their relationship.  
“I believe it was the obsession to have another child and ignored other important 
things. Going for consecutive cycles without considering the risk and not even 
consider the financial burden and the time required”. (Fm6, went through different 
unsuccessful cycles). 
As discussed before, in Middle Eastern societies procreation is highly valued and can 
therefore influence the dignity and self-esteem of a woman if she cannot bear healthy 
children (Serour, 2008). In contrast, an infertile man is not faced with the same 
pressure due to societal privileges. Furthermore, the blood line is culturally important 
in the Islamic societies where it serves as a strong ideological support of a progeny 
kinship for the paternal family. In addition, males are allowed to marry a second wife 
if the first is unable to achieve a pregnancy (Inhorn, 2007).   
One participant reported that their relationship was under strain due to the 
accumulation of stressful circumstances of unsuccessful PGD in addition to the burden 
of having many living affected children and the amount of care that this required. On 
the other hand, the partner did not report a threat to their relationship, but did express 
a stressful dynamic. 
“me and my partner went through a very stressful life full of challenges, 
every child born was a shock, all came sick. We never thought to break our relation. 
As the life goes on, we accepted our fate, tolerated the pain and continued the care 
needed. Now we were hoping for a big success, but it did not happen. The treatment 
was stress, a big stress” (Family 4, affected children, PGD cycle, no healthy embryos). 
Two participants described their experience with an impression of happiness and 
satisfaction, however this was not surprising as they were from families who had had 
a successful pregnancy. Unfortunately, the wives of both couples were not available 
and the female’s perspective may have been different. 
Four participants out of the ten who completed treatment stated that they had a good 
experience (40%).  Two of them (20%) felt it was a “good start” which gave them 
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insight and improved understanding of the treatment. Although the couples were 
unsuccessful in achieving a pregnancy they were motivated to continue with another 
cycle. The other two felt that PGD was an acceptable experience but disappointing as 
they were not prepared for the unsuccessful outcome. One participant felt it was just a 
solution, and the experience was fine while the partner felt it was exhaustive.  In 
contrast, one couple felt it was a difficult experience.  
“It was difficult, very difficult. Emotionally and physically. I had lots of embryos 
and none were healthy. I had to be in a treatment that caused many side effects. I 
had to be in all this stress and the result was distressing” (Fm4-F, went through PGD 
cycle with no healthy embryos).  
Overall most families (60%; 6/10) reported that the treatment experience was stressful. 
The two participants with the successful pregnancy were motivated and happy. As 
expected, families with no healthy embryos or where healthy embryos had failed to 
implant were disappointed. The reported perceptions are congruent with other studies 
where couples describe the experience as distressing or joyful depending on the 
outcome (Järvholm, Broberg & Thurin-Kjellberg, 2014; Lavery et al., 2002). Some 
participants felt that they would be more anxious if future trials were to be considered. 
In general, disappointing news associated with unsuccessful PGD cycles correlated 
with the length of time required to make a decision for another trial. This was seen in 
three of the four families with an unsuccessful outcome. Two participants felt that they 
would not be able to tolerate another cycle if it did not result in an unaffected 
pregnancy. As a result, they considered natural conception for the future pregnancy 
hoping for the 75% chance of having an unaffected child (as for autosomal recessive 
inheritance).  
“I still find PGD best option, I’m not sure if I am ready to go again for my 
next pregnancy. I will go for a natural pregnancy, though I am concerned about 
taking the risk. Yes, we have 75% opportunity for healthy, but I never had it. PGD 
also was disappointing” (Fm4-F, had affected, no healthy, unsuccessful PGD) 
Two of the couples, who went through unsuccessful trials, wanted to delay the decision 
before considering another cycle. All families, including those who oscillated between 
PND and PGD, considered PGD the best option for future pregnancies. Six participants 
associated the actual decision with availability of financial resources (42%). On the 
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other hand, some linked the next plan with their emotional readiness (21.4%; 3/14). 
Two families were waiting till after delivery (naturally conceived pregnancy) before 
considering arrangements for future PGD plans. The participant who felt that repeating 
PGD 20 times (mentioned earlier) would still be better than having an affected child, 
emphasised that the PGD stress was short lived while living with an affected child 
could bring suffering and stress for years: 
“the stress of living with an affected child stays for years. It is very difficult 
to see your children suffer. Yes, PGD is stressful but still better than having another 
affected child” (Fm2-M, one healthy, lost many affected, unsuccessful PGD cycle). 
As reported in many studies, the burden of having an affected child motivated the 
family to consider PGD (Alsulaiman & Hewison, 2006; Farra et al., 2008; Järvholm, 
Broberg & Thurin-Kjellberg, 2014; Kalfoglou, Scott & Hudson, 2005; Karatas et al., 
2010b; Lavery et al., 2002; Wah Hui et al., 2002). However for some families, if that 
desire cannot achieved through PGD, they would rather not have a child who might 
be at risk to be affected.  
In general, Participants reported stressful experience of PGD motivated by desire for 
healthy child, avoidance of termination which conflicts with their religious beliefs. 
They experienced anxiety during several stages of the treatment procedure, and mostly 
to the embryos and pregnancy test. They were confronted with unforeseen conflicts 
with their religious and cultural backgrounds such as insemination, loss of intimacy 
and freezing or discarding embryos. Majority of the families consider the treatment 
very private and were secretive to avoid society stigma on the child. Despite having a 
stressful experience most families felt it brought them closer and strengthen their 
relation. The trauma of distressing outcome had impacted on negatively on some 
participants as they felt overwhelmed and hesitant to consider another cycle. 
Nevertheless, even oscillating between PND and another PGD, 78% would consider 
PGD as their preference for future pregnancy. All participants would recommend PGD 
as an option for families who suffer from a genetic problem. Two participants were 
motivated to become a support resource for other families considering PGD. Of 
importance, none of the participants discouraged others from considering PGD as an 




Chapter 5. Conclusion  
5.1. Introduction 
This chapter will discuss the conclusion of the study findings and recommendations 
for future practice. It will also provide suggestions for potential areas for further 
research.  
5.2. Conclusion  
The aim of this study was to explore the experience of Omani families who have 
elected to undergo PGD as a means for reducing the risk of having a child affected 
with a genetic disorder. The service of PGD is very new to Omani patients and the 
factors that affected the decision making, facilitators and obstacles had not been 
explored before. Therefore, understanding these factors might help to improve the 
current service. The current research is thus valuable as it highlighted these issues. 
Furthermore, the study explored these families expectations of PGD and the impact of 
their preconceived ideas on their real experience.  
This study was conducted using semi-structured interviews with fourteen participants 
from eight families. Five main themes were identified from the collected data:  
 Theme one was the desire for healthy child, which was considered the main 
motivating factor for PGD. It was chosen to avoid a stressful reproductive 
experience considering the restriction of TOP imposed by their religious 
belief.  The desire to procreate was encouraged by religious and cultural mores.  
 Theme two was anxiety during the whole journey of PGD due to: waiting for 
the genetic diagnosis; waiting for financial grants; waiting for enrolment at the 
PGD centre and having to travel abroad. It was found that although couples 
long for a healthy child, the amount of time and care dedicated to the affected 
child played a role in the timing of PGD. It also affected the selection of the 
centre as some families had to consider neighbouring countries so that they 
could visit their children when necessary. Couples found themselves being 
nervous and anxious during the entire lengthy treatment. They also reported 
stress during the procedure because of side effects from the treatment. The 
biggest concerns were for the status of embryos and their suitability for 
implantation. This was reportedly as stressful as waiting for pregnancy test 
results. Sixty percent of the participants who completed at least one PGD cycle 
felt the treatment was stressful.  
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 Theme three was the unexpected traumatic experiences, such as loss of 
intimacy and privacy, masturbation for “semen sample collection”, freezing or 
discarding of embryos and unexpected attachment to their embryos.  
 Most participants considered the PGD-IVF treatment private and dealt with it 
secretly. This was addressed in the fourth theme where 62% of participants 
believed that they could be stigmatised for undergoing unnatural procreation 
and that their child could be labelled as a Haram ("sinful") baby. 
 Theme five describes the impact of the treatment on the participants' 
relationship. Most reported that the treatment brought them closer and made 
them more appreciative of one another. However, three felt the treatment 
experience was sometimes stressful enough to negatively impact on their life 
dynamic.   
  
Although this study focused on a small group of PGD users in Oman and reported on 
the experiences of a single hospital centre, valuable insights have been identified. 
Nonetheless, the findings of this study cannot be generalised to PGD users seen in 
other hospitals or from other Middle Eastern population groups. Further study would 
be required to research these aspects. It would also be useful to explore the correlation 
between the natural history of a disease, reproductive history, recurrent miscarriage 
and termination of an affected pregnancy in terms of their roles as facilitators or 
barriers to PGD in a larger cohort. 
5.3. Practical implications and recommendations 
In the current study, some participants recommend having a centralised service with a 
clear referral system/pathway for communication and arrangements through genetics, 
obstetrics and gynaecology and the IVF-PGD centre (50%; n=7). They felt that there 
was a gap in counselling regarding the minor details of the IVF treatment (P3 and P6). 
However, most had reported that the current service was satisfactory and supportive. 
Perhaps it would be important to create awareness of the role of the genetic clinic being 
limited to providing genetic counselling about PGD testing, limitations and required 
referrals, while the IVF treatment should be discussed by the IVF-PGD centre.  
Incorporating the recommendations made by the participants as well as those identified 
by the researcher into service development for the PGD clinic at the GDM will 
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contribute towards an improved understanding of PGD and enhanced genetic 
counselling service. These suggestions include: 
 a discussion of the experience of PGD based on previous users perspectives 
during the PGD counselling session. This could incorporate discussion about 
difficulties, stressors and unexpected experiences. Providing this information 
will aid couples in making well-informed decisions and in understanding the 
procedures;  
 increasing public awareness and acceptance of PGD through social media, 
press, magazines, radio, e-forums and the internet; 
 providing an information booklet with detailed descriptions of the PGD/IVF 
procedure and its limitations. The researcher has started compiling these 
booklets by contacting the PGD centres for information to be included. These 
booklets will include general information on the technology, treatment, 
preparations and investigations required, prices, time required for the treatment 
and the potential outcomes. It will also highlight salient topics raised by 
participants. The booklet will also contain religious perspectives on embryo 
selection, cryopreservation and masturbation which was found to be crucial for 
families awareness and preparation. The booklet will be available in Arabic; 
 connecting new families considering PGD with the participants from this study 
who expressed interest in sharing their experiences. Being able to discuss the 
procedure with other families who have undertaken PGD will be important in 
facilitating decision-making. In addition, as families often keep their PGD 
procedure a secret from their own relatives, this will provide an additional 
means of support; 
 the development of a flow-chart and tick-sheet of all the steps related to the 
PGD journey, which is lengthy and involves individuals being seen at multiple 
centres with different specialists. This will promote transparency around the 
service and procedure and prevent confusion; 
 standard letters of support, for use to obtain financial assistance, are now 
offered to all families seen for genetic counselling of PGD since identifying 
this need in the study. These letters include information on the inherited nature 
of the disease, recurrence risk, lack of treatment as well as reasons for 
undergoing a PGD procedure.  
78
 Apart from concerns about PGD, three participants recommended creating public 
awareness about the importance of premarital genetic testing. These participants felt 
that it should be mandatory as is the case in some other Middle Eastern countries. 
Many countries in the Middle East have established compulsory premarital screening 
for haemoglobinopathies (sickle cell anaemia and B-thalassemia). To the researcher's 
knowledge, none of these programs achieved more than the 43% recurrence reduction 
of B-thalassemia which was reported in Bahrain (Saffi & Howard, 2015). Some 
countries such as Saudi Arabia, Iraq and Jordan reported that social pressures resulted 
in more than 80% of at risk couples not cancelling the marriage. Stressing the 
importance of providing PGD services might alleviate the recurrence burden from at 
risk couples who would not consider marriage cancellation due to social influences.  
 However, as this is one of the cornerstone strategies for the GDM clinic, building data 
for the common mutations would provide support for future premarital screening 
programs. At present, the PGD clinic offers targeted familial preventative programs. 
This embraces recommendations to create awareness among affected families for the 
importance of premarital genetic testing to reduce the burden of recurrence.  
Some participants recommended avoidance of consanguinity (P1 and P7), while one 
participant promoted awareness of the importance of genetic counselling among his 
social circle (family, friends, neighbours and work colleagues) (P1). These individuals 
recommended avoiding intermarriage, using their own   experience as an example. 
5.4. Recommendations for further study: 
Based on the outcome of this study, the following points are recommended for future 
research :  
 A longitudinal research study to explore the impact of the PGD experience at
different stages of the treatment.
 A study on the process of decision making perhaps with a larger sample size to
identify facilitators or barriers on the decision to undergo PGD.
 An in-depth study to measure the impact of factors such as natural history of
the disease, miscarriages and PND experiences on the desire for PGD
 Further study to understand the perceptions of families who deferred PGD




 Further studies on couples who undertook PGD through different institutes to 
compare their experiences with the current study.   
 In-depth study on the families who underwent unsuccessful PGD cycles, 
exploring how that impacted their future reproductive plans and motives for 
PGD. 
In summary, participants reported stressful experiences of PGD motivated by the 
desire for a healthy child and avoidance of termination which conflicts with their 
religious beliefs. They were anxious throughout the treatment procedure, mostly due 
to worry about the embryos and the pregnancy test. They reported unexpected conflicts 
with their religious and cultural backgrounds including masturbation, loss of intimacy 
and freezing or discarding of embryos. Most of the families considered the treatment 
very private and were secretive to avoid societal stigma towards the child. The trauma 
of an unfavourable outcome impacted negatively on some participants, leaving them 
feeling overwhelmed and hesitant to consider another cycle. Nevertheless, 78% would 
prefer to consider another PGD before PND for a future pregnancy. All participants 
would recommend PGD as an option for families who suffer from a genetic problem. 
Two participants were motivated to become a support resource for other families 
considering PGD.  Importantly, none of the participants would discourage others from 
considering PGD as an option despite their stressful experiences.  
As this is the first in-depth qualitative study on Arab Muslim PGD users, many unique 
viewpoints were identified which need to be considered in future counselling of Omani 
couples considering PGD. These include issues that had not been addressed in previous 
counselling or reading materials provided prior to the PGD procedure. Being 
unprepared was traumatic for couples when it conflicted with their religious and 
cultural beliefs. Societal and religious beliefs on procreation, the desire for large 
families, and procedural aspects such as masturbation, embryo selection and 
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Appendix D: 
Interview questions in English 
The experiences of couples undergoing Preimplantation Genetic Diagnosis (PGD) at 
the Genetic and Developmental Medicine clinic, Sultan Qaboos University Hospital 
(SQUH) in Oman. 
Objectives: 
 Describe the reasons and motives for pursuing PGD
 Describe the participants’ perceptions and expectations before enrolling into
the PGD procedure.





Number of children: 
Number of affected children (alive/dead): 
History of miscarriages, stillbirths, etc. : 
Name of the genetic disease: 
Number of affected vs healthy 
Name of the disease: 
Region: 
Stage in process 
How many cycles 
B. Motives
1. Can you please tell me the story of your PGD?
The researcher started with one open ended question like this one and the rest
below will act as guide lines [As the researcher gained experiences with
interviews, the researcher was able to pick up on issues as the participants speak].
If the answer of the main open ended question is not sufficient, the questions below
were further used.
1. What options did you have for reproductive planning?
2. Would you consider any of these options (options besides PGD)?
3. Why did you decide on PGD?
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4. Could you please describe what you understand about the actual PGD 
process (what PGD testing entails)? 
5. Can you tell me about your view on PGD in terms of a religious, moral 
and cultural acceptability?   
C. Decision making experience  
1. Currently at what stage are you in the PGD process? 
2. How long did it take to reach this stage (from the time you decided to 
undertake PGD)? 
3. How do you feel about PGD now? (anxious, excited, upset, scared, 
nervous, hesitant, etc)? 
4. Was there anything that made it easier to reach this stage of your PGD 
process (facilitators)? 
5. What are the difficulties (barriers) you faced in reaching this stage of the 
PGD process? 
6. What do you expect will happen next? 
D. Social dynamics  
1. In your social network did you discuss your PGD plans with anyone? 
2. Did you receive sufficient support from your family and, or friends?  
3. Which of both partners had the strongest wish for PGD? (male, female, 
both). 
4. Did the experience impact on your family, marriage relationship, 
children, parents and siblings?  
5. Did you receive sufficient support from professional team?  
E. Recommendations 
1. Overall, how do you describe this experience?  
2. Do you recommend this option to others? 
3. Has your experience been very different to your expectations? 
4. How has the experience affected you?  
5. Will you consider this option for your next pregnancy plan? 
6. Do you have any recommendations or suggestions to improve the 
experience? 
F. Miscellaneous: 
G. Would you like to share anything else related to PGD which you think might 
be useful for all of us? 
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Interview questions in Arabic  
 أسئلة المقابلة
الت  التي اختارت التلقيح الصناعي مع الفحص قبل الغرس كوسيلة لإلنجاب عن طريق  دراسة تجربة العا
 عيادة الطب الوراثي و التطوري بمستشفى جامعة السلطان قابوس
 بيانات شخصية  .1
 العمر :
 المنطقة :
 مرحلة التعليم :
 عدد األطفال :
 عدد األطفال المصابين )على قيد الحياة / متوفين (:
هاضات / وفيات األجنة:   عدد اإلج
 اسم المرض / التشخيص :
الج :  مرحلة ال
الج:  عدد دورات ال
 الدوافع و المحركات .2
) الباحث يبدأ بهذا السؤال المفتوح و الذي قد تغطي  ؟ PGDال أخبرتني من فضلك عن تجربتك مع ال  .1
ة المذكورة أدناه(. إجابته على  معظم نقاط البحث، في حالة عدم استيفاء اإلجابة يلجأ الباحث لألسئل
ا هي الخيارات المتاحة لديك في خطة اإلنجاب؟ .2  م
ن هذه الخيارات باإلضافة إلى ال  .3  ؟PGDهل كنت ستختار أيا م
ذا فضلت هذا الخيار؟ .4  لم
 الذي تسعى له؟ و الفحص PGDهل بإمكانك أن تصف ماذا تعرف عن خطوات ال  .5
ة نظرك حول ال  .6 خالقي؟ و اإلجتماعي؟ PGDهل بإمكانك أن تخبرني عن وجه  من حيث التقبل الديني؟ ا
 تجربة صنع القرار  .3
 ؟ PGDفي أي مرحلة أنت اآلن من مراحل ال  .1
 ؟ PGDكم المدة الزمنية التي استغرقتها لتصل لهذه المرحلة منذ اتخذت القرار باختيار ال  .2
 ؟ متحمس؟ متخوف؟ متردد؟ متضايق؟ قلق؟ متوتر؟ PGDمذا تحس اآلن بشأن ال  .3
ن هنالك عوامل مستعدة للوصول لهذه المرحلة؟ .4  هل كا
ها للوصول لهذه المرحلة؟ .5 ا هي الصعوبات التي واجهت  م
 ماذا توقع في المرحلة المقبلة؟ .6
 المحاور اإلجتماعية .4
 في محيط القاتك اإلجتماعية؟  PGDمع م تناقشت عن ال  .1
 هل لديك دعم اجتماعي كافي؟ .2
 ؟ PGDأي الزوجين كان له الرغب األقوى في اختيار ال  .3
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القة األسرية و الزوجية؟ الوالدين؟ األخوة؟ .4  ما هو تأثير هذه التجربة على العائلة؟ ال
 كيف أثرت التجربة عليك؟ .5
 هل تلقيت دعم كاف من الطاقم الطبي؟ .6
 التوصيات  .5
 بصفة عامة كيف تصف التجربة؟ .1
هذا الخيار آلخرين؟ .2  هل ترشح 
 هل كانت تجربتك مختلفة جدا عن توقعاتك؟ .3
 هل ستختار هذه الطريقة للحمل القادم؟ .4



























Invitation for participation in English 
I am Khalsa Al-Kharusi, an Msc student in the MSc genetic counselling program at 
the Division of Human Genetics, Faculty of Health Science at University of Cape 
Town. As part of my study I am doing this research study of "The experiences of 
couples undergoing Preimplantation Genetic Diagnosis (PGD) at the Genetic and 
Developmental Medicine clinic, Sultan Qaboos University Hospital (SQUH) in 
Oman”. 
I am inviting you to participate in this study and would appreciate if you could attend 
an interview to be conducted by the researcher. Your confidentiality and personal 
information will be stored in a safe locked place where only be accessed by the 
researcher and supervisors.  
The information to be collected from this study can be at a benefit of understanding 
the experience and needs of the families enrolled at PGD procedure and might be at a 
help to improve the current provided service.  
If you have further questions kindly contact the researcher (Khalsa Al-Kharusi 



















Invitation for participation in Arabic 
 
 دعوة للمشاركة بمشروع بحث علمي 
الوراثي في قسم علم الوراثة في كلية الطب بجامعة  أنا خالصة الخروصية طالبة ماجستير في تخصص االرشاد
الت العمانية التي اختارت التلقيح الصناعي مع الفحص  كيب تاون أقوم بإجراء بحث علمي لدراسة  تجربة العا
ها من قبل  الت التي يتم متابعت هي دراسة نوعية مستفيضة. هذه الدراسة تشمل العا قبل الغرس كوسيلة لإلنجاب و 
لطب الوراثي و التطوري بمستشفى جامعة السلطان قابوس. عيادة ا  
ها مراعاة  هذه الدراسة و سأكون ممتنة بموافقتكم إلجراء المقابلة البحثية و التي سيتم في أدعوكم للمشاركة في 
خصوصية و سرية المعلومات الشخصية. سوف يتم تخزين المعلومات الشخصية و الهوية في مكان محكم و ال 
عليها سوى الباحث و المشرف على البحث.يطلع   
ها و قد تكون ذات  الت العمانية و معرفة احتياجات المعلومات المحصلة من البحث قد تساعد في فهم تجربة العا




( أو المشرف على 24144384ات يمكنكم التواصل مباشرة مع الباحثة )خالصة الخروصية لمزيد من المعلوم




















Research Consent Form in English 
 
Study Title: The experiences of couples undergoing Preimplantation Genetic 
Diagnosis (PGD) at the Genetic and Developmental Medicine clinic, Sultan 
Qaboos University Hospital (SQUH) in Oman. 
I understand that I am participating in this research of study of "The experiences of 
couples undergoing Preimplantation Genetic Diagnosis (PGD) at the Genetic and 
Developmental Medicine clinic, Sultan Qaboos University Hospital (SQUH) in 
Oman”. 
I have been informed about the confidentiality and non- disclosure of my identity or 
that of my family. The interview will be digitally recorded and I have no objection 
regarding that. I have no objection of publication of the results of the research study in 
peer reviewed journals, presentation at conference or utilization for education and 
teaching purposes.  
I am fully aware that this study is intended to improve the quality of the service and I 
have no conflict of interest. I am not receiving any payment or privileges of being part 
of this study and understand that this study will not cause me any harm. I have been 
assured that I can withdraw the study with no expected harm to me or my family and 
a psychological support will be provided if needed.  
 
Name of participant:     












Research Consent Form in Arabic 
إقرار بالموافقة للمشاركة بدراسة بحثية
الت التي اختارت  التلقيح الصناعي مع الفحص قبل الغرس كوسيل لإلنجاب: دراسة نوعية دراسة تجربة العا
 مستفيضة
الت التي اختارت التلقيح الصناعي مع  أقر بالموافقة للمشاركة في الدراسة البحثية التي تهدف لدراسة تجربة العا
ما أنني قد بالبحث. ك الفحص قبل الغرس كوسيلة لإلنجاب و أوافق على المشاركة بالمقابلة و اإلستبيان المرفق
 أطلعت على قوانين حفظ سرية المعلومات لدى الباحث و عدم مشاركة بياناتي الشخصية و العائلية. 
ها  ها في المؤتمرات العلمية و استخدام ة أو عرض جالت العلمية المحكم ال أمانع على نشر نتائج البحث في ال
 ألغراض التعليمية.
ة و ليس لدي مصالح شخصية خاصية. كما أنني لم أستلم أتفهم أن الغرض من الدراسة هو  لتحسين و تطوير الخدم
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